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ABSTRACT 
 
As a part of cancer research and therapy, it is important to study metabolic responses 
caused by DNA damaging agents. Whereas earlier studies have focused on changes at 
protein levels caused by DNA damaging agents, this project focuses on establishment of 
sampling and cultivation protocols for metabolome analysis, using Saccharomyces 
cerevisiae as a model organism growing in exponential phase. Sampling and cultivations 
protocols were optimized before cultures were stressed by DNA damaging agent. At the 
time of sampling, cells and extracellular media were separated by filtration prior to 
quenching and extraction in 75% boiling ethanol. Solvent evaporation under reduced 
pressure and ambient temperature were used for metabolite concentration. Yeast 
cultures were exposed to osmotic stress and two concentrations of the DNA damaging 
agent 5-fluorouracil. Samples were taken prior to stress exposure, at the time of 
exposure and in intervals after stress exposure. Metabolite extracts were analyzed by 
GC-MS single quadrupole in respect of amino acids, citric acids cycle intermediates and 
fatty acids. Generally, citric acid cycle intermediates were most influenced by stress 
agents, followed by amino acids and fatty acids. GC-MS single quad was the only 
analytical method applied. For a more complete metabolic profiling, including other 
groups of metabolites, LC-MS/MS should be applied. This analytical method will cover 
groups, such glycolytic intermediates, which can not be analyzed by GC-MS, due to their 
volatility.   
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1 INTRODUCTION 
 
1.1 Saccharomyces cerevisiae as a Model Organism 
 
Microbes are less complex systems to be studied and show advantages over higher 
organisms. Gene regulation, metabolic network and physiology are therefore much more 
studied in microbial cells compared to higher eukaryotic systems (1). One of the main 
criteria for model organism is the compliance to experimental manipulation. 
Saccharomyces cerevisiae (S.cerevisiae), also referred to as yeast, fulfills the criteria as 
well as it grows on defined media, which enables control of chemical and physical 
environment. Use of S.cerevisiae as a model organism, to understand different biological 
aspects of the eukaryotic cell, has increases over the last several decades due to its 
compliant properties (2).    
 
In 1996, S.cerevisae was the first eukaryotic specie to have its complete genome 
sequenced (3). By complete sequencing of the yeast genome, the more complex human 
genome can be understood. Similarities in human and yeast amino acid sequence are 
seen in nearly half of the proteins known to be defective in human heritable diseases. 
Suggestions are purposed that the majority of the yeast has human homologs. However, 
the human genome specifies proteins which are not seen in yeast (3).  
 
Forster et al (2003) show that <30% of metabolites are involved in only two enzymatic 
reactions, while 12% is involved in >10 reactions and 4% is involved in >20 reactions. 
This reveals that metabolic network is closely linked and analysis of single metabolites 
is needed for an overall understanding of interaction of the metabolic activity in a cell.    
 
1.2 Metabolite Analysis 
 
Metabolomics are defined as a systematic analysis of large number of low molecular 
weight compounds from a biological system (4). As a term, it includes quantification of 
extracellular and intracellular metabolite concentrations (5). Metabolite levels of an 
organism will reflect responses to genetic or environmental changes in a biological 
system (6). For metabolite analysis, a large number of metabolites must be extracted, 
the extract must be representative for the whole culture, the metabolites must be 
separated from other cell components and the metabolic activity must be stopped 
immediately after sampling (7). Because all criteria rarely are fulfilled simultaneously, 
inactivation and extraction methods are often optimized to fulfill the criteria in the best 
manner.   
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1.2.1 Inactivation, Extraction and Concentration of Intracellular Metabolites 
Rapid inactivation of metabolism is needed to keep the in vivo metabolite concentration 
at a constant level from time of sampling to time of analysis (6). For analysis of 
intracellular metabolites, cells and media are separated. Intracellular metabolites are 
thereby concentrated and disturbance from natural extracellular metabolites are 
avoided (7). Filtration and centrifugation are two commonly used methods for 
separation of cells and media. After separation, intracellular metabolites are made 
available for analysis by extraction process. High temperatures, extreme pH, organic 
solvents, mechanical stress or a combination can be used as extraction methods (8). 
Extraction solutions re-dilute the metabolites, and freeze-drying, also called 
lyophilization, and solvent evaporation are two available methods for metabolite 
concentration. Sample preparation from sampling until the last concentration is referred 
to as quenching and extraction methods or protocols.  
 
In 1976, Saez and Lagunas presented a protocol which combined cell separation and 
quenching by filtration and washing the cells with 60% methanol. De Koning and Van 
Dam (1992) revealed that filtration could not be applied for metabolites with short turn 
over times, and presented an improved protocol which proposed direct quenching in 
60% cold methanol followed by centrifugation. Direct quenching followed by 
centrifugation is still the most widespread method for rapid sampling for microbial 
cultures (4).  
 
Common criteria for an ideal metabolite extraction are complete extraction so the 
complete intracellular pool is accessible, effective inactivation of enzymes to prevent 
metabolite changes under sample preparation and absence of extensive degradation of 
metabolites by the procedure itself (8-10). Examples of different extraction methods 
studied are freeze-thaw in liquid nitrogen (11), chloroform (9), direct quenching and 
extraction by 75% boiling ethanol (10), chloroform; methanol buffer, boiling ethanol, 
perchloric acids, potassium hydroxide, methanol; water and pure methanol (6) and hot 
water, boiling ethanol, chloroform; methanol, freeze-thaw in methanol and acidic-
acetonitril methanol (8). Different extraction methods favor some classes of compounds 
and even discriminations within classes do appear (6). A combination of extraction must 
be applied to cover the diversity of chemical and physical properties of metabolites. The 
choice of sample preparation methods must therefore be coherent with the aim of study 
and metabolites of interest (5).   
 
When sampling preparations includes several steps, addition of intern standards are 
useful for determination of metabolite recoveries and to register which stages causes 
the largest losses of metabolites (8).  
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1.2.2    Analytical Methods 
1.2.2.1 Enzymatic Reactions 
Phosphorylated hydrocarbon is relatively similar in regard of their polarity and 
structure, which challenge the analysis. Enzyme assays can easily separate and quantify 
glycolytic intermediates, as well as being a quick and simple method. Concentrations are 
proportional to production or use of NADH or NADPH, measured by increase or 
decrease of absorbance at 340nm respectively. Metabolite concentration in extracts can 
be estimated by comparing change in absorbance with change in absorbance from 
assays with standards. Enzyme assays for analysis of glucose-6-phosphate (G-6-P), 
fructose-6-phosphate (F-6-P), dihydroxyacetone phosphate (DHAP), fructose-1,6-
biphosphate (F-1,6-BP) and pyruvate were used in this project. All the above 
metabolites are part of the glycolysis, and quantifications will reflect the central 
metabolism. Reaction mechanism for each metabolite is explained below.      
 
Glucose-6-phosphate 
Glucose-6-phosphate dehydrogenase catalyzes the oxidation of glucose-6-phosphate to 
6-phosphoglucono-δ-lactone while NAD+ is reduced to NADH, resulting in increased 
absorbance. Reaction mechanism is shown in Figure 1.  
 
 
Figure 1-Reaction mechanism of production of 6-phosphogluconate 
 
Fructose-6-phosphate 
Glucose-6-phosphate isomerase catalyzes the isomerization of fructose-6-phosphate to 
glucose-6-phosphate. For quantitative measurements the reaction is coupled with the 
reaction in Figure 1, because no production or use of NADH is observed in the 
isomerization reaction. The reaction mechanism of fructose-6-phosphate to glucose-6-
pjosphate is shown in Figure 2.  
 
 
Figure 2-Reaction mechanism of production of glucose-6-phosphate from fructose-6-phosphate 
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Dihydroxyacetone phosphate 
Glycerol-3-phosphate dehydrogenase catalyzes production of glycerol-3-phosphate from 
DHAP. NADH is used and absorbance decreases as the reaction proceed. The enzyme is 
delivered in combination with triose-phosphate isomerase, which catalyzes the 
formation of glyceraldehyde-3-phospahte from DHAP. This enzyme is also referred to as 
triose phosphate dehydrogenase. No change in absorbance is seen in the latter reaction 
mechanism. Both reaction mechanisms are shown in Figure 3.   
 
 
Figure 3-Reaction mechanism of production of glyceraldehyde-3-phosphate and glycerol-3-phospahte from 
DHAP. 
Fructose-1,6-biphosphate 
Fructose-1,6-biphosphate aldolase converts fructose-1,6-biphosphate to 
glyceraldehyde-3-phosphate and DHAP. No production or use of NADH is involved in the 
reaction, and it is therefore coupled to the reaction in Figure 3 for quantitative 
measurements. The reaction mechanism of production of glyceraldehyde-3-phosphate 
and DHAP from fructose-1,6-biphosphate is seen in Figure 4.  
 
 
Figure 4- Reaction mechanism of the production of glyceraldehyde-3-phosphate from fructose-1,6-
biphosphate 
Pyruvate 
Lactate dehydrogenase (LDH) catalyzes the production of lactate from pyruvate, as seen 
in Figure 5. Pyruvate concentration is estimated by the decreased absorbance of NADH.   
 
Figure 5-Reaction mechanism of production of lactate from pyruvate. Lactate dehydrogenase is abbreviated 
LDH 
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1.2.2.2 Gas Chromatography 
The principle of chromatography is the migration of analytes through a column. Analytes 
are carried on mobile phase and interacts with stationary phase in the column. 
Interactions between mobile phase and stationary phase determine the retention time 
of analyte. Retention time is the time taken for an anlayte to pass through a column. In 
gas chromatography (GC) mobile phase is gas, typically nitrogen or helium and 
stationary phase is a solid. Volatility of each analyte determines the rate through the 
column and so does its solubility in stationary phase (12). For analyzes the sample is 
introduced to the injector, where evaporation takes place, before entering the column by 
the carrier gas. By changing the temperature in the column, analytes are separated by 
their volatility. At the end of the column, the analytes enter the detector, for example 
mass spectrometer. Key elements of a gas chromatograph are shown in Figure 6.  
 
 
Figure 6- The key element of a gas chromatograph (13) 
 
For GC analyses analytes must be volatile. In metabolomics nonvolatile metabolites are 
of interest such as as amino acids, sugars, small organic acids, polar metabolites and 
apolar metabolites. Metabolites can be made volatile by derivatization, covering 
carboxylic, hydroxylic and apolar side groups are covered with either methyl group or 
silylan (13).  
 
1.2.2.3 Mass Spectrometry 
Mass spectrometry (MS) as a detector provides high sensitivity, can give both structural 
and chemical information and can analyze complex samples, which makes it a versatile 
detector in the field of chromatography. Any compound carrying charge, or which can be 
charged and evaporated can be analyzed for mass to charge ratio (m/z), which is the 
core principle in MS. Over the years, there has been extensive development of MS, 
improving the sensitivity, expanded the range of molecules that can be determined, and 
reducing the prize as well as they are more easily to operate nowadays (13). Three units 
compose a MS; ionization, separation and detection. (13). The ion source transfers the 
samples into gas phase, if not already evaporated as in GC, ionizes the samples and 
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transfers it to vacuum. Electron ionization is the most common ionization technique. The 
metabolites are exposed to high-energy electrons, leaving positive ions, M+. The ions 
carry much more energy than the parent molecule, and are frequently fragmented. 
Fragmentation is reproducible and characteristic for single metabolites, and can be 
compared to reference spectra for identification (12). Under ionization molecule-
molecule collision is avoided by applying high vacuum. The newly made ions are lead to 
the analyzer by an acceleration plate with higher potential. A repeller plate inside the 
ionization source controls the electric field. The positions of acceleration and repeller 
plate are shown in Figure 7. High temperature prevents condensation and high vacuum 
removes non-ionized compounds as well as carrier gas. (13). 
 
 
Figure 7- Ionization source (13) 
 
The analyzer consists of four parallel cylindrical rods, quadropole, given direct (U) and 
alternating current (V0) in radio frequent range. The voltage supply is connected to 
adjacent rods, making the ions spinning in a cylindrical pattern. Large ions will spin in 
smaller circles, whereas smaller ions spin in larger circles. Keeping the U/V0 ratio and 
frequency constant, ions with different mass to charge (m/z) ratio will move towards 
the detector one by one. If only alternating voltage is applied all ions hit the detector, 
called scan mode. Applying varying direct voltage, only ions with specific m/z ratio will 
reach the detector, called single ion monitoring (SIM). SIM mode is much more sensitive 
and foremost used for target analysis. On the contrary scan mode is used for profiling 
and dealing with unknown metabolites. Scan mode will be used for identification of 
metabolites in the following experiments (12, 13).  
 
Detection in MS is based on the conversion dynode and electron multiplier. One ion 
hitting the conversion dynode, releases secondary ions which hits an electron multiplier 
and a cascade of electrons is released and more than 105 electrons generate a current. 
The current it further amplified and measured by either an analog or digital converter 
(13). A mass spectrum shows the abundance of each ion mass of an ionized and 
fragmented analyte as a function of its mass to charge ratio.  
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1.3 Building a Deconvolution Reporting Software (DRS) Library 
 
Each metabolite is fragmented in a specific way and process a unique mass spectrum 
when GC-MS is applied. A DRS library holds a set of mass spectrum for selected 
metabolites. Compounds or peaks in chromatograms can be identified if the mass 
spectrum matched a mass spectrum in an established DRS library. The ion with the 
larges abundance is called the target ion (TI), and the following three ions called 
qualifier ion 1, 2, and 3 (Q1, Q2 and Q3). If the ratio between TI and qualifier ions 
matches the ratio in the library and the retention time is correct the presence of a 
certain metabolite is verified. Several components can appear in the same peak, but have 
slightly different retention times. Each component is identified by their unique spectra. 
This is illustrated in Figure 8. In addition to qualifiers, the whole spectra for each 
metabolite must be evaluated as a whole.  
 
 
Figure 8- Illustration of identification of several components in one peak in a chromatogram by applying 
deconvolution (14) 
 
When building a DRS library, metabolites to be included are MCF-derivatizated and 
analyzed by GC-MS. The data programs involved in the production of a DRS library are 
AMDIS and ChemStation. Each chromatogram is analyzed in AMDIS to define its 
retention time and recording of electron impact ionization mass spectrum (EI 
spectrum). The spectra are evaluated and TI, Q1, Q2 and Q3 selected. To program 
ChemStation part of a library, mass to charge ratio for TI, Q1, Q2, and Q3, and the ratio of 
qualifiers to TI are written. So are the name of each compound, its retention time, a 
certain CAS number, file name, company ID and uncertainties in percentage. 
ChemStation displays TI, Q1, Q2 and Q3, whereas AMDIS shows the whole spectra. An 
example of how data are displayed after applying a library is shown in Figure 9.   
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Figure 9-An example of a result screen after DRS are applied on a metabolic extract 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Showing metabolites in library 
 
Upper: Raw spectra from sample 
Middle: Extracted spectra from sample 
Lower: Library spectra 
Showing relative abundance of target 
ion and qualifiers in the library, Exp%, 
and what is found in the analyzed 
extract, Act%.  
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1.4 Stress Agent 5-Fluorouracil 
 
Anticancer drug promote cell damage of cancer cells. Such drugs can either inhibit 
biosynthetic processes or be incorporated into macromolecules or both. The 
fluoropyrimidine 5-fluorouracil (5-FU) is used in treatment of colorectal cancer for more 
than 40 years and represents both mechanisms above. It is a uracil analog, where the 
hydrogen atom at the fifth carbon is exchanged with a fluorine atom, Figure 10, and 
enters the cell in the same way as uracil (15). Fluorine does not alter the overall shape of 
the nucleic acid base, but changes the chemical properties so the compound does not 
function in cell metabolism. Nucleic acid synthesis is therefore blocked (16).  
 
 
Figure 10- Structures of uracil and 5-fluorouracil 
 
Intracellular, 5-FU is converted to active metabolites such as FdUMP, FdUTP and FUTP, 
which disrupt the RNA synthesis and thymidylate synthase (TS) activity. TS converts 
dUMP to dTMP by reduced folate (CH2THF) as methyl donor, shown in Figure 11. This 
represents the single synthesis of dTMP, which is necessary for DNA replication and 
repair. FdUMP bind to the nucleotide binding side on the enzyme. TS, FdUMP and 
CH2THF form a stabile ternary complex, blocking the binding of dUMP and thereby 
inhibiting the synthesis of dTMP (17, 18). 
 
 
Figure 11-Mechanism of thymidylate synthase (TS) inhibition by 5-fluorouracil (15) 
       
 
   Uracil    5-fluorouracil 
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The inhibited synthesis of dTMP leads to depletion of dTTP which again causes changes 
in the production of other deoxynucleotides, through feedback mechanisms. Imbalances 
in deoxynucleotide pools are thought to disrupt DNA synthesis and DNA repair leading 
to lethal DNA damage (19, 20), shown in Figure 12.  
 
Figure 12-Metabolism of 5-fluorouracil (15) 
 
Normal RNA processing and function are disrupted by incorporation of FUTP, leading to 
loss of reproductive characteristics shown in human colon and breast cancer cell lines. 
5-FU incorporation can result in toxicity to RNA at several levels, and disrupt many 
aspects of RNA prossessing. This can lead to profound effects on cellular metabolism and 
viability.  
 
Different schedules been applied to determine optimum dose and mode of 
administration. However, treatment of 5-FU alone gives relative low response rate, 10-
15%. Modulations of 5-FU has successfully increased its anticancer activity by reducing 
the degradation of 5-FU, increasing the 5-FU activation and increasing the thymidylate 
synthase (TS) binding activity of FdUMP. Leucovorin are used to increase the 
intracellular levels of CH2THF which ensure optimal binding of FdUMP to TS, and 
enhances the stability of the ternary complex. To diminish the degradation of 5-FU, 
several strategies has been developed to inhibit the enzyme DPD which degrades 5-FU 
to DHFU. Methotrexate (MTX) is the last modulator strategy being described. MTX 
inhibit synthesis of purine enhancing the levels of PRPP, which is a cofactor required to 
convert 5-FU to FUMP. Giving MTX before 5-FU as shown to increase the anticancer 
activity of 5-FU. Response rate changed from 10 to 19% and overall survival changed 
from 10,7 to 9,1 month going from singly 5-FU treatment to combination of MTX and 5-
FU (21).  
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1.5 Aim of Study 
 
Cytostatic agents used in cancer therapy affect healthy cells as well as the targeted 
cancer cells. By the use of model organism, illustrating healthy cells, earlier research 
have studied the effect of cytostatic agents on protein levels. This project aims to 
develop sampling and analytical protocols for the study of metabolic changes of single 
intracellular metabolites. Metabolites showing diverging affect by DNA damaging agents 
might be a target for making the treatment less harmful for healthy cells or the cytostatic 
agent more effective.  
 
For intracellular metabolite analysis, it is important neither to overestimate nor 
underestimate its concentrations. Intracellular metabolite concentration will be 
underestimated if leakage occurs under sample preparation. The first aim of this project 
was therefore to evaluate the extent of leakage of intracellular metabolites in two 
sampling methods by the use of shaking flask cultivations. The two methods were 
evaluated in respect of glycolytic intermediates by using enzyme assays. Enzyme assays 
were optimized in respect of volumes of standards and enzymes added to reach end 
point within 2-3 minutes. 
 
The second aim was to up-scale preliminary experiments to fermenter size of 1L, add 
stress agents and analyze metabolic changes before stress exposure, at the time of 
exposure and a time series after stress exposure. For identification of peaks in 
chromatograms, a DRS library with 83 metabolites was made prior to the experiments. 
Since this project was one of the first experiments studying single metabolites, the focus 
was to get an overview of metabolic changes caused by stress agents.  
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2 MATERIALS AND METHODS 
 
2.1 Shaking Flask Cultivation 
2.1.1 Mineral Media 
Mineral media used for preliminary studies in shaking flask, was adopted from Verduyn 
et al (1992). Stock solutions are presented in Appendix I- Stock Solutions. Cultivation 
concentration of glucose, nitrogen, phosphate and magnesium is shown below. 
 
Mineral  g/L 
Glucose  5,0 
(NH4)2SO4  5,0 
KH2PO4  3,0 
MgSO4   0,5 
 
2.1.2 Cultivations 
Initially, S.cerevisiae CEN pk (CEN pk) and S.cerevisiae BY 4743 (BY 4743) were provided 
by Per Bruheim. Freeze stocks of each strain were made by growing 100µL of each strain 
in 0,5 X YSPG media for 24 hours at 30oC and 220 rpm in Infors HT Minitron incubator 
shaker. 0,5 X YSPG media consists of 5g/L Yeast Extract and 20g/L Soyton Pepton and 
will be referred to as rich media onwards. 45mL culture from each rich media culture 
were transferred to two separate sterile 50mL tubes, and centrifuged for 2 minutes at 
5000 rpm at room temperature. Approximately 25mL of supernatants were decanted, 
followed by addition of 5mL sterile glycerol and the tubes vigorously shaken to re-
suspend the pellets. 1mL of re-suspended pellets was allocated in 25 separate ampoules. 
All ampoules were marked properly, and stored at -80oC.  
 
For cultivation in rich media, 100µL freeze stock was used as inoculum. If not stated 
otherwise, 500µL culture grown in rich media for 24 hours was used as inoculum for 
mineral media cultivations. All cultures were incubated at 30oC and 220rpm in Infors HT 
Minitron incubator shaker.    
 
Whenever needed, pH was measured after calibration with buffer 4 and 7 by Radiometer 
Copenhagen pH, Standard pH meter.  
 
2.1.3 Sampling 
In this project, two quenching protocols were tested in preliminary experiments, for 
comparing which method giving least leakage of intracellular metabolites into 
extracellular media. The quenching protocols are described in detail below. Extraction 
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by freeze-thaw in liquid nitrogen and concentration by lyophilization was used for both 
quenching methods. OD was measured at the time of sampling.  
 
Filtration prior to quenching 
5 mL of culture were filtrated on a 0,8µm Milipore filter placed on a vacuum filtration set 
up, and washed with 2 x 5mL 2,63 % NaCl. The filter was transferred to 50mL tubes 
holding 25 mL 60 % methanol pre-cooled to -40oC, given a short and vigorous shake and 
placed in -40oC cryostat. The filtrates were collected soon after and placed in cryostat. 
Filtrates and tubes with filter were treated equally onwards. If several samples were 
taken at the same time, all were filtrated and placed in cryostat before they were given a 
quick vortex and placed in liquid nitrogen for 5 minutes for extraction. Thereafter, the 
samples were thawed in cryostat for approximately 15 minutes. From the point of 
vortexing, the procedure was repeated two more times. After the last thawing, filter 
pieces were removed, and the tubes centrifuged for 5 minutes at 8000 rpm and -9oC in a 
pre-cooled centrifuge. The volume of supernatants transferred to empty tubes pre-
cooled to -400C were adjusted to obtain the desirable amount of replica. Equal volume of 
water as supernatants was added to the tubes to lower the alcohol content to make them 
freeze at -80oC prior to lyophilization.  
 
Direct quenching followed by cold centrifugation 
5mL culture was transferred to a tube holding 25 mL pure methanol pre-cooled to -45oC, 
followed by centrifugation at 4000 g for 5 minutes and -20oC in a pre-cooled centrifuge. 
5mL of supernatants were transferred to an empty pre-cooled tube, before the 
remaining supernatants were decanted to a waste beaker. Tubes with pellets were 
placed in the -45oC cryostat, while 5mL of distilled water pre-cooled to ~0oC were added 
to tubes with 5mL supernatants. 2mL chloroform pre-cooled to -20oC, was added to the 
water-supernatants mixture and the tube quickly vortexed. The tubes were centrifuged 
for 5 minutes, 5000 g and -20oC. 5mL of the methanol phase were transferred to sterile 
15mL tubes and another 5mL of pre-cooled distilled water was added. The tube was 
stored at -80oC until freeze-drying took place.  
 
Prior to extraction, the pellets were resuspended in 12,5mL 50% methanol pre-cooled to 
-45oC, quickly vortexed and placed in liquid nitrogen. After 3-5 minutes the tube was 
thawed in ice bath for 3-5 minutes. The process from vortexing was repeated two more 
times. After extraction the tubes were centrifuged at 5000 g for 5 minutes at -20oC. The 
supernatant was decanted to pre-cooled empty tubes in cryostat and the pellets 
resuspended in 12,5mL 50% methanol, given a quick vortex and centrifuged again under 
the previous conditions. The supernatant was decanted into the tube already holding the 
first supernatant. 5mL chloroform, pre-cooled to -20oC, was added and the tube quickly 
vortexed before another centrifugation. 8mL of the methanol phase was transferred to 
sterile tubes followed by addition of 8 mL MiliQ water pre-cooled to ~0oC. The tube was 
stored at -80oC until freeze-drying took place. 
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2.1.4 Analysis 
Enzyme assays were used to analyze G-6-P, F-6-P, DHAP, F-1,6-BP and pyruvate. 
Concentrations of stock solutions, volumes added and final concentrations of  TEA 
buffer, KCl, MgCl2, NADH and NADP+ for each reaction was adapted from De Koning and 
Van Dam (1992). Final volume was completed to 1mL by MiliQ water. The use of NADH 
and NADP+ in the respective reactions was measured by decrease and increase in OD at 
340 nm, using Ultraspec 200 UV/Visible Spectrophotometer, and are proportional with 
concentrations. According to Beer-Lambert law, the valid measuring range were 0,1-0,8. 
 
Prior to measuring in metabolic extracts, standards were used to stipulate the delta OD 
for a certain concentration of metabolites. Delta OD in metabolic extracts was compared 
to results from assays with standards, and the concentration in extracts estimated. The 
amounts of enzyme added were optimized to reach end point within 2-3 minutes 
reaction time.     
 
Glucose-6-Phosphate and fructose-6-phosphate: 
100 µL 0,5M TEA buffer, 10 µL 0,5M MgCl2 and 40µL 10 mM NADP+ were added to each 
reaction. 10mM G-6-P and 10mM F-6-P standards were added in varying volumes and 
OD measured prior to addition of varying volumes of G-6-P dehydrogenase. At end point, 
G-6-P isomerase was added in varying volumes to measure F-6-P. Either the volume of 
enzyme or standards were changed at the time. Delta OD was measured for each trial, 
and the optimal amounts of G-6-P and F-6-Pstandards and G-6-P dehydrogenase and G-
6-P isomerase were found. 
 
Dihydroxyacetone phosphate (DHAP) and fructose-1,6-biphosphate: 
100µL 0,5M TEA buffer and 15µL 10mM NADH were added to each reaction. 10mM 
DHAP standard and 10mM F-1,6-BP standard were added in varying volumes and OD 
measured prior to addition of G-3-P dehydrogenase/triose phosphate isomerase mix. At 
end point, F-1,6-BP aldolase was added in varying volumes. Either the volume of enzyme 
or standards were changed at the time. Delta OD was measured for each trial, and the 
optimal amounts of DHAP and F-1,6-P standards and G-3-P dehydrogenase and F-1,6-BP 
aldolase were found. 
 
Pyruvate: 
100µL 0,5M TEA buffer, 100µL 1M KCl, 20µL 0,5M MgCl2 and 15µL 10mM NADH were 
added to each reaction. 0,1M and 10mM pyruvate standard were added in varying 
volumes and OD measured prior to addition of lactate dehydrogenase in varying 
volumes. Either enzyme or standard volumes were changed at the time. Delta OD was 
measured for each trial, and the optimal amounts of pyruvate standard and lactate 
dehydrogenase was found. 
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2.1.5 Dry Weight Measurements and Correlation Curve of Gram Dry Weight 
Per Liter and OD 
For dry weight measurements of a suspension, liquid is transferred to dried and pre-
weighted aluminums scales, and incubated in Termaks incubator holding 110oC 
overnight. The scales are weighted the day after, and the change in weight being the dry 
weight of the suspension. For estimation of dry weights in cultures, a correlation curve 
showing OD in relation to gram dry weight per liter was made for each strain. 40mL, 
20mL, 10mL, 5mL and 2,5mL culture were transferred to separate sterile 50 mL tubes, 
and volumes completed to 40mL using 1,5 % NaCl (aq). OD was measured in each tube, 
prior to centrifugation for 5 minutes at 6000 rpm at room temperature. The 
supernatants were decanted and pellets resuspended in 20mL 1,5  % NaCl (aq), and 
centrifuged under same conditions. Supernatants were decanted, and the pellets re-
suspended in the smallest volume possible using MiliQ water. Re-suspended pellets 
were transferred to dry and pre-weighted aluminums scale and dry weight measured as 
described above. 
 
2.2 Fermenter Cultivation 
 
The fermenter part of this project is performed in cooperation with master student 
Simon Rey. Mineral media, cultivation condition and sampling protocols will therefore 
be similar in both reports, whereas implementation of analytical protocol is performed 
individually.  
  
2.2.1 Mineral Media 
The glucose concentration in mineral media from preliminary studies was increased, 
from 5 to 80g/L, to reach stationary phase at a desirable OD. The other minerals were 
added in the equal amounts as in preliminary studies, except doubling of vitamin 
concentration. Stock solutions are presented in Appendix I- Stock Solutions. 
Concentration of glucose, nitrogen, phosphate and magnesium are shown below. 
 
Mineral  g/L 
Glucose  80 
(NH4)2SO4  5,0 
KH2PO4  3,0 
MgSO4   0,5 
 
2.2.2 Cultivation 
The following fermenter cultivations were done in 1L New Brunswick fermenter with 
working volume of 700mL. The fermenter was programmed to hold temperature at 
30oC, pH at 5 and dissolved oxygen (DO) at 40 % by auto adjusting agitation. Regular 
calibration of pH probe, O2 probe, O2 saturation and CO2 saturation were performed 
RESULTS 
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prior to inoculation.  The inoculum was prepared by transferring a desired volume of 
culture grown in rich media into sterile 50mL tube and centrifuge for 5 minutes at 5000 
rpm at room temperature. The supernatant was decanted and the pellets re-suspended 
in approximately 5mL of mineral media from the fermenter, and added to the fermenter 
for inoculation. OD was measured in rich media and the volume used for inoculation in 
the fermenter adjusted so the culture had a certain OD at a wanted time of sampling.  
 
2.2.3 Sampling 
5mL culture was sampled from reference cultivation and culture exposed to osmotic 
stress, whereas 10mL were sampled from cultures exposed to 0,1mM and 0,5mM 5-
fluorouracil. The sampling volume was transferred to 0,8 µm Milipore filter placed on a 
filtration setup and washed two times with volumes of 2,63% NaCl equal the sampling 
volume. The filter was placed in a tube containing 7mL 75 % ethanol pre-heated to 95oC 
and 10µL 10mM d3-alanine internal standard added before 3 minutes incubation. 
Thereafter the tube was placed in -40oC cryostat until centrifuged for 5 minutes and 
5000 rpm at room temperature. The filter was removed before centrifugation. 5mL 
supernatant were transferred to sterile 15 mL tube and the solvent evaporated at 60oC 
using SAVANT SPD2010 SpeedVac Concentrator from Thermo Electron Corporation.  If 
not evaporation was done directly, the tubes was held in cryostat. After evaporation and 
before analysis, the tube was stored at -80oC.  
Internal standard were added to normalize metabolic results to internal standard and 
thereby calculate metabolic recoveries.  
 
2.2.4 GC-MS Analysis 
For analysis of metabolite extracts gas chromatography system Agilent Technologies 
7890 A GC System and mass spectrometer system Agilent Technologies 5975 inert Mass 
Selective Detector (GC-MS SQ) was used, shown in Figure 13. Metabolite extracts were 
derivatized using methyl chloroformate (MCF) and N-methyl-N-
trimethylsilytrifluoroacetamide (MSTFA). Derivatization protocols are described below. 
 
 
Figure 13-Picture of the GC-MS SQ used in this project 
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2.2.4.1 MCF Derivatization 
Following the method of Villas-Bôas et al (2003), metabolite extracts were dissolved in 
380µL 1M NaOH, and the entire volume transferred to silylated tubes. 20µL d5-
glutamate was added as internal standard, prior to addition of 333 µL methanol and 67 
µL pyridine and the tube quickly vortexed. 40µL MCF was added and the tube vortexed 
for 30 seconds, before an additional 40µL MCF and vortexed for another 30 seconds. 
400µL chloroform was added, and vortexed for 10 seconds before 400 µL NaHCO3 was 
added to the tubes and a final vortex for 10 seconds. The chloroform phase was 
transferred to new silylated tubes. Three spoons of dried Na2SO4 were added to remove 
residual water (22). The chloroform was thereafter transferred to marked vials with 
inserts and caps were placed on. The samples were analysed immediately using the 
SKLMCFRTL#2_mod method on GC-MS SQ. Specifications of method are not included in 
this report.   
 
2.2.4.2 MSTFA derivatization 
This derivatization protocol was adopted from Kind et al (2009) for applying the 
commercially available Agilent Fiehn Library to identify metabolites not identified by 
AMHSKL or SKLMCFD2 library. 5mL 40g/L fresh O-methylhydroxylamine hydrochloric 
acid in dried pyridine was prepared daily. Metabolite extracts were dissolved in 300 µL 
O-methylhydroxylamine hydrochlorine in pyridine, 100µL of dissolved metabolite 
extracts were transferred to vials with inserts and vortexed for 30 seconds. The vials 
were incubated at 30oC for 90 minutes on a shaker. 100µL MSTFA with 1% 
trimethylchlorosilane (TMCS) was added and vials incubated on a shaker for another 30 
minutes at 37oC (23). Vials were covered with caps and samples analysed immediately 
using the method SKLFMLDR on GC-MS SQ. Specifications of method are not included in 
this report.   
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3.1 Shaking Flask Cultivations 
3.1.1 Characterization of Growth 
Under batch fermentations nutrients will eventually be exhausted and stop growth. This 
is called the limiting nutrient. Growth curves of batch cultures give a characteristic 
sigmoid shape, where exponential phase is represented in the linear area when plotted 
in semi-log scale. Batch growth profiles were characterized for both strains prior to 
exposure of stress agent. CEN pk was grown in mineral media, whereas BY 47473 was 
grown in mineral media with addition of leucine, histidine, methionine and uracil due to 
auxotrophy. Three glucose concentrations were tested for the amount of biomass 
obtained, data not shown. 5g/L glucose resulted in enough biomass for sampling, and 
this concentration was used onwards. To investigate how pH in mineral media effects 
growth, both strains were grown in one mineral media in which pH was adjusted to 5 
and another mineral media which was not pH adjusted. Growth profile in both mineral 
media is shown in Figure 14-A for CEN pk and Figure 14-B for BY 4743. The same dry 
weight yields are reached for culture grown in pH adjusted mineral media and culture 
grown in not pH adjusted mineral media. Based on these results pH will not be adjusted 
during the rest of the study. Metabolome sampling in exponential phase much be done 
before OD 3, where stationary phase appears.  
 
 
 
Figure 14-pH and OD measurements for cultivations with pH in mineral media adjusted to 5 and pH not 
adjusted for A) CEN pk and B) BY 4743 
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3.1.2 Correlation Curve of Gram Dry Weight Per Liter and OD 
A correlation curve, for each strain, showing grams dry weight per liter (g DW/L) in 
relation to OD was made to estimate amount of dry weight sampled from the fermenter 
or shaking flask and analyzed. Correlation curves are shown in           Figure 15. Raw data 
are presented in Appendix II- Raw Data From Correlation Curve of Gram Dry Weight Per 
Liter and OD.  
 
           Figure 15- Correlation curve of gram dry weight per liter and OD for CEN pk   
      and BY 4743, its raw data can be seen in Appendix II.  
For BY 4743, OD measured divided by factor 3 gives gram dry- weight per liter. 
For CEN, OD measured divided by factor 2,5 gives gram dry-weight per liter. 
 
3.1.3 Optimization of Enzyme Assay 
Enzyme assays for quantification of G-6-P, F-6-P, DHAP, F-1,6-BP and pyruvate were 
established to enable quick quantitative analyses of metabolite extracts. Delta OD from 
extracts was compared with delta OD from enzyme assay with standards and the 
concentrations in extracts estimated. Concentrations of stock solutions, volumes added 
and final concentrations of  TEA buffer, KCl, MgCl2, NADH and NADP+ for each reaction 
was adapted from De Koning and Van Dam (1992). Assays were optimized in respect of 
volumes of standards and enzymes added to reach end point within 2-3 minutes and OD 
measuring range between 0,1 and 0,8. Substrate must be the limiting reactant for 
estimation of its concentration. When increasing the amount of substrate, a linear graph 
is seen when change in OD is plotted against volume of substrate added. For all the 
reactions below, increased volume of substrate resulted in equal increase in delta OD. A 
summary of the results from optimization is described below, whereas raw data and 
graphic presentation for all reactions are presented in Appendix III- Raw Data From 
Enzyme Assay Optimization.  
 
G-6-P and F-6-P 
The optimized volumes were 1µL for both G-6-P dehydrogenase and G-6-P isomerase, 
and 5µL of both 10mM G-6-P and 10mM F-6-P. 100µL 0,5mM TEA buffer, 10µL 0,5M 
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MgCl2 and 40µL 10mM NADP+ were added to each reaction. Both 5 and 10µL standard 
was tried out using 1 and 2µL enzyme for both reactions. Using 1 and 2µL enzyme gave 
the same time for reaching end point. For economic reasons, 1µL enzyme was selected.    
 
DHAP and F-1,6-BP 
The optimized volumes were 1µL of both G-3-P dehydrogenase/triose isomerase mix 
and F-1,6-BP aldolase, and 2µL of both 10mM DHAP and 10mM F-1,6-BP. 100µL 0,5M 
TEA buffer and 15µL 10mM NADH were added to each reaction. Delta OD for F-1,6-BP is 
generally higher than DHAP.  
 
Pyruvate 
The optimized volumes were 3µL lactate dehydrogenase and 3µL 10 mM pyruvate 
standard. 100µL 0,5mM TEA buffer, 100µL 1M KCl and 20µL 0,5mMMgCl2 were added to 
each reaction. Using 10µL standard the final OD exceeded the measurement range, and 
was therefore excluded. Using 5 and 3µL standard, time taken to reach end point was the 
same, and 3µL chosen to be used for reference.   
 
 
3.1.4 Evaluation of Intracellular Leakage in Metabolic Extracts Using 
Enzyme Assays 
For evaluation of intracellular leakage in the two sampling methods, optimized enzyme 
assays were used for analysis of glycolytic intermediates in intra- and extra cellular 
metabolic extracts. Extracts were re-suspended in MiliQ water prior to analysis, and 
standards were added to each cuvette after end point was reached as a positive control 
for each assay.  
 
Metabolite extracts, from direct quenching followed by cold centrifugation were 
dissolved in 2mL MiliQ water, except extracellular extracts from CEN pk which was 
dissolved in 1mL. Three parallels with 100 and 200µL extracts were analyzed. Delta OD 
was measured for each reaction and compared with delta OD from reference assays. 
Delta OD of samples showed 0,001 and 0,002, whereas addition of standards gave 
expected results confirming functionality of the assay. Delta OD of 0,001 and 0,002 
indicates no metabolite detection by the use of direct quenching.   
 
Extracts from filtration method were dissolved in 600µL MiliQ water and three parallels 
were only analyzed for pyruvate, due to same results as for centrifugation samples. For 
CEN pk 100µL, 200µL and 300µL were analyzed in parallel 1 ,2 and 3 respectively. For 
BY 4743, 200µL were analyzed in each parallel. Delta OD ranged from 0,003-0,007 for, 
whereas delta OD after addition of standards was coherent with reference assays.  As for 
the direct quenching method, no metabolites were detected.  
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20mL culture was sampled from another BY 4743 cultivation, and not allocated in 
replica, giving the same results as above. Addition of standards in extracellular extract 
from BY 4743, showed diverging delta OD compared to results from optimization. All 
results are shown in Table 6, Table 7 and Table 8 in Appendix IV - Measuring Intra- and 
Extracellular Metabolites in Metabolite Extracts Using Enzyme Assays Enzyme assay as 
analytical method was not sensitive enough to be used further. Therefore, enzyme 
assays will be replaced by GC-MS SQ as analytical method. Moreover, other metabolic 
groups, as amino acids, citric acids cycle intermediates and fatty acids, will be analyzed 
by GC-MS SQ.  
 
Two replica of the same extract were dissolved in 30% methanol and 50µL G-6-P and 50 
µL F-6-P added. The tubes were freeze-dried in 17 and 21 hours respectively to 
investigate for any loss of metabolites under this process. 30% methanol was also freeze 
dried over the same time periods for estimation of background noise. Standards were 
added at end point as a positive control for assay. Extracts with additional G-6-P and F-
6-P showed expected results. As far as this experiment shows, there is no loss of G-6-P 
and F-6-P during the process of freeze-drying in metabolic extracts. There are reasons to 
believe that this accounts for other phosphorylated glycolytic intermediates. Only 
methanol did not show any sign of neither G-6-P nor F-6-P, and addition of standards 
after end point showed expected results. In conclusion, only methanol gave no 
background noise and no loss of G-6-P or F-6-P were revealed under the freeze-dry 
process.  
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3.2 Creation of GC-MS DRS Library 
 
A GC-MS DRS library holds a set of metabolites, each with a specific mass to charge ratio 
spectrum at a certain retention time. By GC-MS analysis, each metabolite will appear 
after a certain retention time and in different amounts resulting in peaks in 
chromatograms. Peaks in metabolite extracts can be identified by comparing mass to 
charge ratio spectrum with a library. An original library, SKLMCFD2, consisted of 38 
known and named metabolites and 142 unknown and temporary named metabolites 
identified in Pseudomonas fluorescens and Streptomyces coelicolor extracts. For 
extending the already existing library, a new library with 43 other metabolites were 
made as described in the introduction, and named AMHMCFN2. The latter library was 
combined with known and named metabolites from SKLMCFD2, creating a library 
consisting of 83 known metabolites, named AMHSKL. Metabolites in the different 
libraries are listed in Table 1. The ChemStation part of the library was typed manually, 
and the final document showed in Appendix V- ChemStation Part of the New MCF-DRS 
Library.   
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Table 1- List of metabolites in different DRS libraries 
 
AMHMCFN2 SKLMCFD2 SKLMCFD2 AMHSKL
Metabolites Metabolites Metabolites Metabolites
Methylvalerat 6.3001 min, _FFI_1_2 OH-Proline Methylvalerat
Malanoic acid 6.4634 min, _FFI_1_2 Methionine Tetrachloroethane
3-methyl-2-oxovalerate NNp-40 17.3142 min, _FFI_1_2 Malanoic acid
Methylglyoxal 6.8533 min, _FFI_1_2 17.3287 min, _FFI_1_2 Pyruvate
b-hydroxypyruvat Tetrachloroethane 17.4890 min 31OKT08MCF_MUCA_FFI_1 3-methyl-2-oxovalerate
Citraconate Pyruvate BMAA Pentachloroethane
Benzoat 7.3277 min, _FFI_1_2 17.5086 min, _FFI_1_2 Fumarate-1
Citramalat 7.5110 min, _FFI_1_2 17.8611 min 31OKT08MCF_MUCA_FFI_1 Fumarate-2
Methoxyamine NNp-42 Cysteine d4-Succinate
Nicotinat 7.7532 min, _FFI_1_2 18.0564 min, _FFI_1_2 Lactate
Phenylacetat Pentachloroethane 18.0797 min, _FFI_1_2 Methylglyoxal
M-toluate 7.7977 min, _FFI_1_2 18.1575 min, _FFI_1_2 Succinate
2-aminobutyrat NNp-7 Isocitrate Hexachloroethane
Adipat 8.2387 min, _FFI_1_2 Phenylalanine b-hydroxypyruvat
2-isopropylmalate Fumarate-1 NNp-14 Citraconate
a-ketoadipat Fumarate-2 18.8185 min, _FFI_1_2 Benzoat
g-aminobutyrat d4-Succinate 18.9540 min, _FFI_1_2 Citramalat
Serine Lactate 18.9862 min, _FFI_1_2 Malate-2
Threonine Succinate 19.1640 min, _FFI_1_2 d3-alanine
L-homoserine 9.2608 min, _FFI_1_2 Cadaverine Glycine
O-acetyl-L-serine Hexachloroethane 19.4640 min, _FFI_1_2 Alanine
5-aminovalerat 9.3386 min, _FFI_1_2 19.4929 min, _FFI_1_2 Methoxyamine
Salicylat 9.4319 min, _FFI_1_2 ?? NNp-16 Nicotinat
Anthraniate 9.7085 min, _FFI_1_2 19.7495 min, _FFI_1_2 Phenylacetat
N-acetyl-L-glutamat Malate-2 ? NNp-34 M-toluate
Hydroxyproline d3-alanine 20.1294 min, _FFI_1_2 2-aminobutyrat
Methionine Glycine 20.1942 min 31OKT08MCF_MUCA_FFI_1 Adipat
b-methylamino-L-alanineAlanine 20.2261 min, _FFI_1_2 d8-valine
Putresine 10.2843 min 31OKT08MCF_MUCA_FFI_120.2727 min, _FFI_1_2 Valine
Phenylpyruvat 10.3854 min 31OKT08MCF_MUCA_FFI_120.3183 min, _FFI_1_2 a-ketoglutarate
Hippurat 11.0983 min, _FFI_1_2 NNp-18 2-isopropylmalate
Threo-b-hydroxyaspartat11.1450 min, _FFI_1_2 Ornithine a-ketoadipat
4-imidazoleacrylate 11.1550 min, _FFI_1_2 20.5427 min, _FFI_1_2 Leucine
Allantoin 11.5361 min, _FFI_1_2 NNp-20 Isoleucine-1
2,4-diaminobutyrate ?? NNp-26 20.6560 min, _FFI_1_2 Serine-1
4-aminobenzoat NNp-19 20.7963 min 31OKT08MCF_MUCA_FFI_1 Isoleucine-2
Cadaverine 11.7261 min, _FFI_1_2 20.8616 min, _FFI_1_2 g-aminobutyrat
Oxaloacetat 11.8027 min, _FFI_1_2 20.9093 min, _FFI_1_2 Serine
Histamine d8-valine 21.0404 min, _FFI_1_2 Malate-1
p-coumarate Valine 21.1618 min 31OKT08MCF_MUCA_FFI_1 Threonine
N-glycyl-proline a-ketoglutarate 21.1926 min, _FFI_1_2 L-homoserine
Ferulate ? NNp-43 21.3182 min, _FFI_1_2 Proline
2,6-deaminopimelat 12.5648 min, _FFI_1_2 21.3615 min, _FFI_1_2 Asparagine
Serotonine 12.8815 min, _FFI_1_2 21.4915 min, _FFI_1_2 O-acetyl-L-serine
Library
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AMHMCFN2 SKLMCFD2 SKLMCFD2 AMHSKL
Metabolites Metabolites Metabolites Metabolites
12.9984 min 31OKT08MCF_MUCA_FFI_121.5026 min, _FFI_1_2 Aspartate
13.0448 min, _FFI_1_2 NNp-21 Citrate
13.0526 min, _FFI_1_2 Lysine 5-aminovalerat
Leucine 21.6340 min 31OKT08MCF_MUCA_FFI_1 Salicylat
13.2925 min, _FFI_1_2 21.7081 min, _FFI_1_2 Anthraniate
Isoleucine-1 21.8203 min, _FFI_1_2 Serine-2
13.3981 min, _FFI_1_2 21.9514 min, _FFI_1_2 Glutamine
13.4103 min, _FFI_1_2 21.9806 min 31OKT08MCF_MUCA_FFI_1 d5-glutamate
Serine-1 Histidine Glutamate
Isoleucine-2 22.2836 min, _FFI_1_2 N-acetyl-L-glutamat
13.4869 min, _FFI_1_2 NNp-25 OH-Proline
Threonine 22.5036 min, _FFI_1_2 Hydroxyproline
NNp-9 22.5969 min, _FFI_1_2 Methionine
Malate-1 22.6913 min, _FFI_1_2 b-methylamino-L-alanine
Proline NNp-38 Cysteine
13.9680 min, _FFI_1_2 ? NNp-45 Isocitrate
Asparagine Tyrosine Phenylalanine
14.0249 min 31OKT08MCF_MUCA_FFI_123.7168 min, _FFI_1_2 Putresine
Oxaloacetate 23.8793 min 31OKT08MCF_MUCA_FFI_1 Phenylpyruvat
14.0883 min 31OKT08MCF_MUCA_FFI_124.0070 min 31OKT08MCF_MUCA_FFI_1 Hippurat
14.1835 min, _FFI_1_2 NNp-37 Threo-b-hydroxyaspartat
14.4846 min, _FFI_1_2 24.1211 min, _FFI_1_2 4-imidazoleacrylate
14.5604 min 31OKT08MCF_MUCA_FFI_124.2434 min, _FFI_1_2 Allantoin
?? NNp-10 24.3025 min 31OKT08MCF_MUCA_FFI_1 2,4-diaminobutyrate
NNp-44 24.3825 min 31OKT08MCF_MUCA_FFI_1 4-aminobenzoat
14.8901 min, _FFI_1_2 24.4803 min 31OKT08MCF_MUCA_FFI_1 Cadaverine
Aspartate 24.5492 min 31OKT08MCF_MUCA_FFI_1 Oxaloacetat
Citrate 24.6247 min 31OKT08MCF_MUCA_FFI_1 Histamine
?? NNp-33 24.9410 min, _FFI_1_2 p-coumarate
15.2212 min, _FFI_1_2 Tryptophan Ornithine
15.3067 min, _FFI_1_2 25.2132 min, _FFI_1_2 N-glycyl-proline
15.3678 min, _FFI_1_2 25.6921 min, _FFI_1_2 Lysine
15.3759 min 31OKT08MCF_MUCA_FFI_125.9298 min, _FFI_1_2 Histidine
15.4678 min, _FFI_1_2 25.9590 min 31OKT08MCF_MUCA_FFI_1 Ferulate
15.7266 min, _FFI_1_2 25.9720 min, _FFI_1_2 Tyrosine
NNp-1 26.0023 min 31OKT08MCF_MUCA_FFI_1 2,6-deaminopimelat
Serine-2 26.0820 min, _FFI_1_2 Tryptophan
Glutamine 26.1068 min 31OKT08MCF_MUCA_FFI_1 Serotonine
NNp-12 26.2834 min 31OKT08MCF_MUCA_FFI_1
? NNp-11 26.4086 min, _FFI_1_2
16.1211 min, _FFI_1_2 26.6522 min 31OKT08MCF_MUCA_FFI_1
NNp-15 26.7633 min 31OKT08MCF_MUCA_FFI_1
NNp-13 26.8189 min 31OKT08MCF_MUCA_FFI_1
16.4666 min, _FFI_1_2 26.9300 min 31OKT08MCF_MUCA_FFI_1
d5-glutamate 27.1077 min 31OKT08MCF_MUCA_FFI_1
Glutamate 28.3995 min, _FFI_1_2
32.5171 min 31OKT08MCF_MUCA_FFI_1
Library
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3.3 Fermenter Cultivations 
 
Preliminary experiments in shaking flasks were performed for establishing sampling 
protocols to be used for sampling from fermentation cultivations. Fermenter cultivations 
have the advantage of controlled pH and dissolved oxygen can be controlled and kept at 
a constant level. By applying the same mineral media in fermenter cultivations as in 
shaking flask cultivations, stationary phase appeared at approximately OD 2. To ensure 
enough cell material for metabolite analysis, it was desirable to sample around OD 8. For 
the purpose of this project, it was desirable to sample during exponential phase. Several 
cultivations were grown to adjust mineral media so OD 8 appeared in exponential phase 
of the growth profile. The mineral media was only adjusted in respect of the CEN pk 
strain. Optimization of mineral media for BY 47473 would include changes in the 
amounts of amino acids and uracil, and was not carried out due to time limitations. 
Therefore, CEN pk is the only strain to be used onwards. Growth profile obtained by 
applying the final media to be used in fermentation cultivations and growth profile for 
cultivations with mineral media adopted from shaking flasks are shown in Figure 16. 
The major differences in mineral media was the glucose concentration of 80g/L used in 
fermentation cultivations compared to 5g/L in shaking flask cultivations. 
 
 
 
Figure 16- Growth profile for CEN pk in fermenter with mineral media with 5 and 80 g/L glucose 
 
Yield dry weight per gram glucose was calculated to 0,160 in the experiment with 5g/L 
glucose and 0,085 in the experiment with 80g/L glucose. The growth rate, µmax, was 
calculated to 0,41 h-1 and 0,49 h-1 for the experiment with 5g/L glucose and 80g/L 
glucose respectively. This is slower than one duplication per hour, 0,69 h-1. Calculations 
for yield and growth rate are shown in Appendix VI- Calculations of Yield and Growth 
Rate. GC-MS were used for metabolite analysis for all fermentation cultivations, as 
enzymatic assays proved to be less sensitive for shaking flask experiments, refer to 
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subchapter 3.1.4. Moreover, amino acids, citric acid cycle intermediates and fatty acids 
are analyzed by GC-MS compared with glycolytic intermediates when applying enzyme 
assays.   
 
3.3.1 General metabolite analysis 
An example of chromatogram from the analysis by GC-MS is shown in Figure 17. When 
applying a GC-MS DRS library for metabolite analysis, the given number of hit in the 
library is shown as number of targets, blue T in red circle in Figure 17. Not all targets 
appear as large peaks. 47 targets are shown in the figure below, but only 15 relatively 
large peaks are observed. Relatively large peaks identified with the AMHSKL library are 
given letters A-H. Extracts were reanalyzed using the SKLMCFD2 library, and five 
additional metabolites were identified, named X-1 to X-5. Name of each abbreviated 
metabolite is given below.  
 
 
 
             
 
 
 
        X-2   X-3 
  X-4   X-5 
X-1                 
        A        B         C               D   E     F   G     H   
 
Figure 17-Example of AMDIS spectra of metabolite extract from fermenter cultivation. Peak with letters and 
X-1 to X-5 indicates identified metabolites. The red circle shows the symbol indicating a hit in the library 
applied. 
A: Succinate 
B: Alanine 
C: Valine 
D: Aspartate 
E: Glutamat 
X-1: NNp-14 
X-2: NNp-18 
X-3: NNp-20 
F: Lysin 
G: Histidine 
X-4: NNp-25 
X-5: 22.6913min_FFI_1_2 
H: Tyrosine 
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The purpose of this scientific research is to obtain an overview of metabolic changes in 
S.cerevisiae caused by stress exposure. Seven amino acids, succinate and metabolite X-1 
to X-2 will be studied in more detail, being the most abundant metabolites in the above 
chromatogram. Study of other metabolites would be more time consuming. The number 
and type of metabolites studied should also be coherent with the aim of study.  
 
Results from GC-MS analysis were displayed as area under peaks, integration. The base 
line for integration was set automatically, manually inspected and adjusted if needed. 
Differences from automatic and manual base line did appear, emphasizing the need for 
manual inspection. The differences between automatic and manual baseline are more 
pronounced for low abundant metabolites. The importance of correct base line setting 
must be seen in correlation with the aim of study. For the purpose of this semi-
quantitative study it is of less importance, but attention should be paid in experiments 
with other purposes.  
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3.3.2 Metabolome Analysis of Stress Responses 
Batch cultivations of S.cerevisiae were used during this scientific research, meaning that 
the cells grow until one nutrient is limiting its growth. One cultivation was grown and 
not exposed to stress to characterize how metabolite generates under normal 
conditions, referred to as reference cultivation. Three following cultivations were 
exposed to osmotic stress, 0,1mM 5-fluorouracil and 0,5mM 5-fluorouracil.    
 
CO2 in outgas of the fermenter reflect respiration of cells and was measured every 
second in all cultures. For simplicity, every second minute of respiration is displayed in 
graphs showing progression of respiration and OD. OD measurements were taken at the 
time of inoculation and thereafter occasionally to monitor growth, as well as at the time 
of sampling. Response values from chromatographic analysis were normalized to the 
corresponding OD at the time of sampling. Neither of the internal standards was found 
under analysis, and calculation of losses and recoveries during sampling preparation 
was therefore not carried out. In graphs showing progression of respiration and OD, a 
vertical black line indicates the point of nutrient limitation. This line is repeated in 
graphs showing metabolic changes as well as respiration in the time period of sampling. 
A light brown vertical line indicates the point of stress exposure in the latter graphs, and 
the time scale in is limited to the time period of sampling.  
 
The aim of this project is to study changes in metabolite levels before time of stress 
exposure, at the point of exposure and in a time series after stress exposure. Results 
from the semi-quantitative GC-MS method are therefore presented as log2 diagrams. In 
log2 diagrams a doubling of response values from chromatographic analysis are 
displayed as factor 1, and a fourfold increase is displayed as factor 2 and so on. In the 
case of halving and fourfold decrease, factor of -1 and -2 is displayed. In all experiments, 
the basis of log2 calculations is the first sample in the sample series. Succinate, seven 
amino acids and five other metabolites were studied in detail. Interestingly succinate 
showed diverging results compared to the other metabolites. Therefore, three additional 
citric acid cycle intermediates, citrate, malate and fumarate, were also studied in detail. 
For each experiment preformed, graphs with metabolic changes are displayed with 
equal scaling for comparison.     
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3.3.2.1 Reference cultivation 
To examine metabolic levels during exponential phase, a cultivation was grown without 
stress agent exposure, referred to as reference cultivation. Three samples were taken 
during exponential phase (see arrows in Figure 18) and metabolites analyzed.  The 
progression of respiration and OD in reference cultivation is shown in Figure 18. A 
disturbance in respiration can be seen approximately 10 hours after inoculation, caused 
by removal of heating belt for varies reasons. However, it is seen that respiration is 
reestablished after restoration of temperature control, emphasizing its temperature 
dependence. The second drop in respiration is caused by limitation of carbon source. 
Changes in metabolites levels in relation to respiration are seen in  
Figure 19, next page.  
 
 
Figure 18- Progression of respiration and OD in reference cultivation. Arrows shows the point of sampling 
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Figure 19- Changes in metabolite levels at three different OD states shown as log2, and respiration in the time 
interval of sampling for A) amino acids, B) citric acid cycle intermediates and C)NNp-14, NNp-18, NNp-20, 
NNp-25 and 22.6913min_FFI_1_2 
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A general reduction in metabolite level is observed. An exception is the minor increase 
of valine from OD 5,34 to OD 13,72 in in Figure 19-A. Histidine stands out with a small 
increase before showing the smallest reduction of all metabolites together with 
glutamate. Lysine shows the largest degrease of all amino acids. Citric acid cycle 
intermediates in Figure 19-B show diverging changes of metabolic levels. The level of 
succinate is diminished by three-fold whereas citrate is slightly decreased. Malate and 
fumarate shows an increase before a decrease in the same extent as citrate. Metabolites 
in Figure 19-C, show the greatest reduction in metabolite levels. These metabolites show 
the same pattern of changes as the amino acids studied, but to a larger degree. 
Additional samples in stationary phase are needed for comparing metabolic changes in 
exponential and stationary phase. However, highest concentration of metabolites is 
expected to appear in exponential phase. 
 
Increasing concentration of metabolites could be expected in exponential phase. Each 
result is normalized to OD and shows decreased levels as exponential phase proceeds. 
The results contradict with the expected, but might reflect the in vivo situation. How the 
metabolome is affected by the disturbance in temperature is not known. To investigate 
this in more detail, cultivation can be set up without disturbing the temperature and 
taking samples approximately at the same stage in growth.  
 
However, to get a wider understanding of the total growth, additional groups of 
metabolites could be studied using other analytical methods. LC-MS can be applied for 
the study of glycolytic intermediates and nucleotides.   
 
 
RESULTS 
 
- 34 - 
 
  
RESULTS 
 
- 35 - 
 
3.3.2.2 Osmotic stress 
One culture was exposed to 1M NaCl to evaluate how cells respond to osmotic stress. At 
the time of stress exposure, respiration drops instantly, shown in Figure 20. Respiration 
is gradually improved, but does never reach the level prior to stress exposure. The 
second drop in respiration is slow and probably not caused by nutrient limitation, which 
appears as a fast and sudden drop. It is reasonable to believe that the cells are affected 
by the osmotic stress and down regulates its metabolism, resulting in decreased 
respiration. Maximum OD reached in this experiment was 13,48 compared to 16,92 in 
reference cultivation, indicating that the cells are affected when osmotic stress is 
applied.  
 
 
Figure 20- Progression of respiration and OD in culture exposed to osmotic stress 
Figure 21 show changes in metabolites at the time of stress exposure, 5 minutes after 
and 60 minutes after stress exposure, as well as respiration in the time period of 
sampling. No sample was taken prior to stress exposure, which is a drawback in this 
experiment.  
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Figure 21- Changes in metabolite levels at the time of stress exposure, 5 minutes and 60 minutes after 
exposure shown as log2, and the respiration in the time interval of sampling for A) amino acids and succinate,  
B) citric acid cycle intermediates and C) NNp-14, NNp-18, NNp-20, NNp-25 and 22,6913MIN_FFI_1_2 
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A general trend for most metabolites is a decreased level from the first sampling to 
sampling 60 minutes after stress exposure. Two exceptions are levels of lysine and NNp-
25, which slightly increases. In comparison, the level of valine increased in reference 
cultivation, whereas other metabolites decreased. Tyrosine shows the same pattern as 
in reference cultivation by a small increase prior to a decrease. Glutamate, tyrosine and 
valine show increased levels when respiration drops and decreased levels when 
respiration slightly improves. Levels of histidine and valine are relative stable compared 
to the other metabolites. The level of aspartate falls directly whereas all the other 
metabolite levels increases before decreasing. Noticeably, this pattern is not found in 
reference cultivation.   
 
Levels of citric acid cycle intermediates show a larger decreased than the amino acids 
studied. Changes of malate and fumarate show equal pattern, and succinate is the least 
affected citric acid cycle intermediate.  
 
Regarding NNp-14, NNp-18, NNp-20, NNp-25 and 22.6913min_FFI_1_2, the same trend 
is seen as for amino acids. All metabolites show an overall decreased levels, with the 
exceptions of NNp-25. A small increase can be seen before reduction appears, with the 
exception of 22.6913min_FFI_1_2. The larges decrease in this experiment is seen as 
factor -0,5, whereas reference cultivation reveal a decrease of factor -2. The metabolites 
seem to be more stable under stress exposure than in reference cultivation.  
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3.3.2.3 0,1mM 5-fluorouracil 
After exposure of 0,1mM 5-fluorpuracil, respiration drops instantly. A second drop is 
seen after improved respiration. This is most probably caused by nutrient limitations. 
The improved respiration shows the cells capacity to adapt to environmental changes. 
Progression of respiration and OD in the culture is presented in Figure 22.  
 
 
Figure 22- Progression of respiration and OD for a culture exposed to 0,1mM 5FU. Light brown line indicates 
the point of stress exposure and black line indicates point of nutrient limitation. 
For metabolome analysis, one sample was taken before stress exposure, one at the time 
of exposure followed by 5 additional each with 6 minutes time interval. Changes of 
metabolite levels in the sampling period are presented in Figure 23.   
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Figure 23 -Changes in metabolite levels shown as log2 for the sample before stress exposure, at the time of 
exposure and the 5 following with 6 minutes intervals for A) succinate and amino acids B) citric acid cycle 
intermediates and C) NNp-14, NNp-18, NNp-20, NNp-25 and 22.6913min_FFI_1_2.  
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All amino acids show the same pattern of changes, but to different extent. Again, 
histidine show larger increase in the metabolite level than the other amino acids. In 
reference cultivation and the experiment with osmotic stress, histidine show only minor 
changes. Succinate diverges from amino acids studied by a large decreased level. In 
comparison, malate and citrate increases whereas the level of fumarate is relative stable. 
As respiration increases before stress exposure, so does the level of all metabolites. 
Right after stress exposure both respiration and metabolites fluctuates. Trends in 
metabolic changes indicate a possible improvement as respiration improves before the 
point of nutrient limitation.  
 
NNp-14, NNp-18, NNp-20, NNP-25 and 22.6913min_FFI_1_2 shows equal metabolic 
changes. Increased levels are seen from sampling before stress exposure to the point of 
exposure. These metabolites are stable in comparison with amino acids and citric acid 
cycle intermediates.  
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3.3.2.4 0,5mM 5-fluorouracil 
Progression of OD and respiration in culture exposed to 0,5mM 5-fluorouracil is shown 
in Figure 24. A sudden drop in respiration occurs at the time of stress exposure, and is 
not reestablished before nutrient limitation occurs. OD is no longer improving after 
point of stress exposure. It is difficult to estimate what causes the halt of OD because 
point of stress exposure and nutrient limitation occur right after another.  
 
 
Figure 24- Progression of respiration and OD in a culture exposed to 0,5mM 5FU. 
 
Two samples were taken before stress exposure, one at the time of exposure and 10 
samples after stress exposure, each with 6 minutes time interval. The five last samples 
are taken after point of nutrient limitation where metabolic changes no longer are 
caused by stress exposure alone. Metabolic changes after point of stress exposure and 
nutrient limitations reflect changes caused by stress exposure.  Figure 25 and Figure 26 
show metabolic changes and respiration in the time period of sampling.  
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Figure 25- Changes in metabolite levels shown as log2 for samples before stress exposure, at the time of 
exposure and 10 following samples with 6 minutes intervals for A) amino acids and B) citric acid cycle 
intermediates.  
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Figure 26- Changes in metabolites levels shown as log2 for samples before stress exposure, at the time of 
exposure and 10 following samples with 6 minutes intervals for  NNp-14, NNp-18, NNp-20, NNp-25 and 
22.6913min_FFI_1_2.  
Before stress exposure, the level of all metabolites decreases. In comparison metabolic 
changes in the experiment with 0,1mM 5-fluorourail showed increased levels in the 
same time period. All metabolites show increased levels after stress exposure followed 
by decrease to varying extents. In Figure 25-A, histidine differs from the other amino 
acids by a larger increased level after stress exposure. The other amino acids show the 
same pattern of changes after point of stress exposure and before nutrient limitation. 
After nutrient limitation, asparate decreases, histidine stabilizes and the remaining 
amino acids are still varying. No specific correlation between respiration and change in 
metabolite levels are seen in this experiment.    
 
Whereas the level of amino acids increases in the time period of sampling, citric acid 
cycle intermediates decrease. Citric acid cycle intermediates are more influenced by 
stress exposure than amino acids. After point of nutrient limitation, the level of succinate 
improves drastically, whereas the other citric acid cycle intermediates still declines.  
 
Metabolites in Figure 26 show the same pattern of changes. NNp-14, NNp-20 and 
22.6913min_FFI_1_2 reveals larger metabolic changes than NNp-18 and NNp-25. 
Metabolites in Figure 21-C, Figure 23-C and Figure 26 are more stable in experiments 
with stress agent compared to reference cultivation. Comparing the two concentrations 
of 5-fluorouracil, 0,1mM gives largest metabolic changes. The exception is succinate, 
where exposure to 0,5mM gives largest changes. Metabolic changes for single 
metabolites for the two concentrations are presented in Figure 33 and Figure 34 in 
Appendix VII- Metabolic Changes for Single Metabolites.  
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3.4 Identification of Unknown Peaks in GC-MS Chromatogram 
 
Five peaks being unidentified using the library AMHSKL, were identified as NNp-14, 
NNp-18, NNp-20, NNp-25 and 22.6913min_FFI_1_2 when reanalyzes by the SKLMCFD2 
library. Four of the compounds were further identified by names by applying the public 
NIST library. The results are listed below.  
 
Name in SKLMCFD2   Name in NIST library 
NNp-14       Tetradecanoic acid 
NNp-18     Palmitoleic acid 
NNp-20       Palitic acid 
22.6913min_FFI_1_2   Stearic acid 
 
 
3.5 Applying MSTFA Derivatization and Fiehn Library 
 
For identification of additional metabolites in metabolite extracts, MSTFA derivatization 
(23) and commercially available Fiehn library was applied on samples from the 
experiment of 0,1mM 5-fluorouracil. Four additional metabolites were found, being 
porphine, glutamine, mannitol and ergosterol. However, they were only identified for 
qualitative reasons and not studied in detail.  
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4 DISCUSSION 
 
4.1 Sampling and Extraction 
 
In metabolomics, the ultimate goal is to develop a protocol where intact cells are 
separated from the cell culture liquid while preserving the intracellular conditions at 
time of sampling. In this project, two quenching protocols were tested in preliminary 
experiments, for comparing which giving least leakage of intracellular metabolites into 
extracellular media. The first method tested was filtration followed by quenching of cells 
in 60% methanol. The second, direct quenching in pure methanol followed by 
separation of cells and media by centrifugation. Unfortunately, comparisons of the two 
methods failed due to too low amount of cell material analyzed for the analytical method 
used in this introductory part of the master project. Both protocols could have been 
repeated with an increased amount of cell material. However, it was decided to apply 
filtration as separation technique onwards. Direct quenching was rejected as a method 
due to location of equipment. Incubation in quenching solution would be prolonged due 
to transport of equipment from 3rd floor to ground floor for centrifugation.   
 
When sampling from fermentation cultivations, quenching and extraction was carried 
out in one step using 75% boiling ethanol after separation of cells and media by 
filtration. The latter is a modification of the optimal quenching and extraction method 
proposed by Canelas et al (2008), Villas-Bôas et al (2005) and Canelas et al (2009). They 
proposed direct quenching in pure methanol, followed by immediate cold centrifugation 
and extraction in 75% boiling ethanol. The modified protocol was less time consuming 
and easier to perform compared to method of filtration or centrifugation prior to 
extraction in liquid nitrogen. However, it is not possible for a more rapid immediate 
quenching because extraction and quenching do occur in the same step. The modified 
protocol was not evaluated for uncertainties, metabolic recoveries or if it favored groups 
of metabolites. This is a drawback and should be studied further, by using internal 
standards for estimation of metabolic recoveries and analysis of parallels for each 
sample taken.  
 
Filtration prior to quenching is only valid for study of metabolites with long turn over 
times, such as amino acids. Metabolite extracts from fermentation cultivations were 
analyzed in respect of amino acids, selected citric acids cycle intermediates and fatty 
acids, making the use of filtration prior to quenching a valid method. 
 
Lyophilization for metabolite concentration was used when developing quenching 
protocols using shaking flask cultivations, but replaced by solvent evaporation under 
reduced pressure and ambient temperature (SpeedVac) when sampling from fermenter. 
Villas-Bôas et al (2005) presented a diverse recovery pattern depending on the class of 
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metabolites using lyophilization. In this project, no losses of glucose-6-phosphate were 
observed applying the same concentration method. Based on results from Villas-Bôas et 
al (2005) studying several groups of metabolites, solvent evaporation were used as 
concentration method onwards.    
 
 
4.2 Analytical Methods 
 
Enzyme assays were used to analyze glycolytic intermediates in metabolic extracts from 
shake flask cultivations, and GC-MS were used for analyzes of seven amino acids, four 
citric acid cycle intermediates and five fatty acids in metabolic extracts from 
fermentation cultivations. 
 
Internal standards were added right after filtration (d3-alanine) and at the beginning of 
derivatization (d5-glutamate). None of the standards were seen in chromatograms, and 
losses and recoveries of metabolites during sample preparation would therefore not be 
calculated. One possible explanation is that something was wrong with the solutions 
used. The absent detection of internal standards should have been detected during early 
analytical run. However, samples were collected and analyzed at the end of the 
experimental part of the master project. 
 
It was prioritized to study an overview of the metabolic profile of stress exposed S. 
cerevisiae. Even though the DRS library applied included 83 metabolites, only the 11 
most abundant metabolites were studied in detail. The fatty acids studied were 
identified, as tetradecanoic acid, palmitoleic acid, palitic acid and stearic acid, by the 
public NIST library. Applying the commercially available Fiehn library, porphine, 
glutamine, mannitol and ergosterol were additionally identified. Still, groups of 
metabolites are not covered revealing that several analytical methods are needed for 
metabolic profiling. Fermentation part of this project was done in cooperation with 
master student Simon Rey, who applied a third derivatization protocol for the study of 
amino acids. Refer to his report for results on the same samples analyzed in this report. 
LC-MS is one example of another analytical method which can be applied for analysis of 
phosphorylated glycolytic intermediates and nucleotides (24).  
 
Study of nucleotide pool will improve the relevance of this project seen in relation of the 
type of stress agent applied. Changes in nucleotide pool will reflect the direct/primary 
consequence of 5-fluorouracil, whereas changes in amino acids, citric acid cycle 
intermediates and fatty acids are affected indirectly/secondary.  
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4.3 Growth and Experimental Design 
 
More samples are recommended to be taken and analyzed in both exponential and 
stationary phase of a reference cultivation, for better understanding of metabolic 
activity under normal conditions. This will give a basis of evaluating metabolic activity 
seen after stress exposure. The time between stress exposure and the point of nutrient 
limitation must be prolonged compared to what was done in this project. Either stress 
can be applied earlier in exponential phase or more of the limiting nutrient can be added 
making stationary phase appear later, or both of the above.   
 
OD was used as a measure of cell growth. Anyhow, there is not a direct proportionality 
between OD and dry weight, but it is a fast and cheap measurement of cell culture 
progression. Results from GC-MS analysis were normalized to the measured OD at the 
time of sampling. It is believed that it is more correct to normalize to OD compared to 
not doing so. 
 
 
4.4 Stress Agent Exposure - Metabolome Analysis 
 
Only metabolic changes appearing after stress exposure and before nutrient limitations 
are caused by the stress agents. Stress agents in this project were 1M NaCl, 0,1mM 5-
fluorouracil and 0,5mM 5-fluorouracil. To observe metabolic responses over a longer 
time period, it is recommended to apply stress agents earlier, which will lead to a 
prolonged time between point of stress exposure and nutrient limitation. Observations 
of metabolic activity in exponential phase of reproducible reference cultivation are 
needed as a basis for evaluating metabolic changes appearing after stress exposure.    
 
Sampling prior to stress exposure reflect metabolic status under normal conditions, and 
give a basis for evaluation of changes occurring after stress exposure. However, no 
samples were taken prior to application of osmotic stress, which should have been 
performed.  
 
Groups of metabolites tend to be affected in the same way. Citric acid cycle 
intermediates is most affected, followed by amino acids and fatty acids. The fatty acids 
are more stable in stress situation compared to non-stress situations. Compared to 
amino acids and citric acid cycle intermediates only minor metabolic changes are 
observed for fatty acids.  
 
Citric acid cycle intermediates tend to be more influenced by stress exposure than amino 
acids. When respiration falls quickly, succinate level increases. Succinate is most 
influenced and citrate is least influenced in reference cultivation and in the experiments 
of both 0,1mM and 0,5mM 5-fluorouracil. These two intermediates are located early and 
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late in the citric acid cycle. Other citric acid cycle intermediates, as acetyl-CoA, iso-
citrate, α-ketoglutarate, succinyl-CoA and oxaloacetate, can be studied further for a more 
complete picture of how the cycle is affected as a whole.  DRS library used in this project 
includes other citric acid cycle intermediates and only a more detailed study of the 
analyzed samples is needed. Moreover, the additional intermediates probably show low 
abundance compared to those studied in detail.  
 
4.5 Concluding Remarks 
 
For comparative metabolomics, neutral extraction method covering an extensive specter 
of metabolites is preferred. For a narrow focus on specific metabolite groups, use of 
selected extraction methods might be of preference, as for example acidic or alkaline 
solutions. Therefore, the choice of extraction method must be coherent with the aim of 
study. For further study on this project, acidic extraction can be used for extraction of 
nucleotides (6). For a more complete metabolic profiling, including other groups of 
metabolites, LC-MS/MS should be applied. This analytical method will cover groups, 
such glycolytic intermediates and nucleotides, which can not be analyzed by GC-MS, due 
to their volatility.   
 
This research aimed to evaluate metabolic changes caused by the cytostatic agent 5-
fluorourail. 5-fluorouracil is used as cancer treatment, and in a wider perspective it is 
desirable to study how mammalian cells will respond to the same exposure. Genetic 
variations can be studied by using several strains and mutations. DNA repair systems in 
humans are genetically dependent and the use of several strains will improve the 
relevance of the study. However, only one effector must be changed at the time, and 
experimental design must be developed for one strain before moving to the next level in 
research.     
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5-FU:   5-fluorouracil 
DHAP: dihydroxyacetonephosphate 
DHFU: dihydrofluorouracil 
DNA:   deoxyribonucleic acid 
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DRS:  deconvolution reporting software 
dTMP:  deoxythymidine monophosphate or 5’-thymidylate 
dTTP:  deoxythymidine triphosphate 
dUMP:  deoxyuridine monophosphate 
F-6-P:  fructose-6-phosphate 
F-1,6-BP: fructose-1,6-biphosphate 
FdUMP: 5-fluoro-2’-deoxyuridine 5’-monophosphate 
FdUTP:  5-fluoro-2’-deoxyuridine 5’-triphosphate 
FUMP: 5-fluoro uridine 5’-monophosphate or 5-fluoro-uridylate 
FUTP:  5-fluorouridinetriphosphate 
GC-MS:  gas chromatography-mass spectrometer 
G-6-P:  glucose-6-phosphate 
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m/z:   mass to charge ratio 
MCF:  methyl chloroformate 
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MSTFA: N-methyl-N-trimethylsilyltrifluoroacetamide 
MTX:   methotrexate 
NAD+:  nicotinamide adenine dinucleotide 
NADH:  reduced form of NAD+ 
NADP+: nicotinamide adenine dinucleotide phosphate 
NADPH: reduced form of NADP+ 
nm:   nanometer 
OD:   Optical density 
PRPP:  phosphoribosyl pyrophosphate 
Q1:  qualifier 1 
Q2:  qualifier 2 
Q3:  qualifier 3 
RNA:   ribonucleic acid 
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rpm:   rounds per minutes 
TI:   target ion 
TS:   thymidylate synthase 
µL:   microliter 
µm:   micrometer 
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APPENDIX I- STOCK SOLUTIONS  
 
The mineral media for cultivations was based on Verduyn et al (1992). Mineral media 
consists of salt solutions, trace elements, vitamins, magnesium and glucose, which are all 
added from stock solutions. The applied stock solutions are described in detail below. 
 
Salt solution 
5 g/L (NH4)2SO4   (Merck, LOT A801717705) 
3 g/L KH2PO4   (Merck, LOT A672173 637) 
The salts were dissolved in MiliQ water, and 90 mL allocated in separate shaking flasks. 
If the media were to include histidine, methionine, leucine and uracil, these were 
dissolved along with the salts in the following concentrations. 
0,933 g/L Histidine  (Sigma Chemical Company, LOT 57HO386) 
0,121 g/L Methionine (Sigma Chemical Company, LOT 82F-0529) 
0,327 g/L Leucine  (Sigma Chemical Company, LOT 11KO899) 
0,094 g/L Uracil  (Sigma Chemical Company) 
 
Trace element stock solution for shaking flasks cultivations 
0,30g FeSO4*7H2O   (Merck, LOT 1173391) 
0,45g ZnSO4*7H2O   (Merck) 
0,228 g CaCl2    (Merck, LOT F356083 802) 
0,08g MnCl2 *2H2O   (Merck, LOT 9657938) 
0,03g CoCl2 *6H2O   (Reagenzien Merck, LOT 8489035) 
0,4g Na2MoO4 *2H2O 
1 g H3BO3 
0,03g CuSO4 *5H2O   (Acros Organics, LOT A014205301) 
0,01g KI    (Merck, LOT B158343 234) 
1,3g EDTA    (Sigma Chemical Company, LOT 61F-0318) 
The trace elements were dissolved in 1000 mL of MiliQ water, and the pH adjusted to 4 
by 2M NaOH and 0,1M KOH before sterile filtration. 
 
Trace element stock solution for fermenter cultivations 
1,5g FeSO4*7H2O   (Merck, LOT 1173391) 
2,28g ZnSO4*7H2O   (Merck) 
1,13g CaCl2    (Merck Pro Analysis, LOT F356083 802) 
0,5g MnCl2 *2H2O   (Merck, LOT A852327 823) 
0,15g CoCl2 *6H2O   (Reagenzien Merck, LOT 1 025 39 0100) 
0,15g CuSO4 *5H2O   (Acros Organics, LOT A014205301) 
0,2g Na2MoO4 *2H2O 
0,5g H3BO3 
0,05g KI    (Merck, LOT B158343 234) 
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7,5g EDTA    (Sigma Chemical Company, LOT 61F-0318) 
Trace elements were dissolved in 500 mL of MiliQ water one by one holding the pH at 6. 
Prior to addition of EDTA, the solution was gently heated. Finally, pH was adjusted to 4,0 
by 6M and 1M NaOH before sterile filtration. 
 
Vitamin stock solution 
26,8 mg d-biotin was dissolved in 10 mL 0,1 M NaOH, 400 mL distilled water was added 
and pH adjusted to 6,5. The given amounts of vitamins below was added and the pH 
adjusted to 6,5. 
0,500 g  Ca-Pantothenat  (Merck,  LOT 251637  art: 2316) 
0,500 g  Thiamin-HCl   (ACROS Organics, LOT A016611101) 
0,500 g  Pyridoxin-HCl  (Sigma, LOT 76F-0367,No. P-9755) 
0,500 g  Nicotinic acid   (Sigma, LOT 51C-1670, No.N-4126) 
0,100 g  p-aminobenzoic acid  (Sigma) 
12g m-inositol (Sigma, No. I-5125) was added, and pH again adjusted to 6,50. MiliQ 
water was added to complete the volume to 500 mL, before sterile filtration and cold 
storage. 
 
Glucose stock solution for shaking flask cultivations 
100 g glucose  (AnalaR Normapur, LOT 07E070003) 
500 mL MiliQ water 
 
Glucose stock solution for fermenter cultivations 
56 g glucose  (AnalaR Normapur, LOT 07E070003) 
100 mL MiliQ water 
 
MgSO4 stock solution 
25 g  MgSO4 (Merck Pro analysi, LOT 0076819) 
500 mL MiliQ water 
APPENDIX II 
 
VII 
 
APPENDIX II- RAW DATA FROM CORRELATION CURVE OF GRAM DRY 
WEIGHT PER LITER AND OD 
 
For calculation of gram dry weight per liter and its correlated OD, different volumes of 
culture were transferred to sterile 50mL tubes. Volumes were completed to 40mL and 
OD measured. Each tube were centrifuged, the supernatants decanted and pellets re-
suspended in a small volume distilled water. Each suspension was transferred to pre-
weighted scales and dried over- night. The scales were weighted again and the change in 
weight being the dry weight. Calculations were done, and a correlation curve of gram 
dry weight per liter and OD was made. Raw data are shown in Table 2.    
 
Table 2- Raw data from dry weight measurements and correlation curve calculations 
 
CEN BY 4743 
Volume culture 40 mL 20 mL 10 mL 5 mL 2.5 mL 40 mL 20 mL 10 mL 5 mL 2.5 mL 
OD 2,37 1,35 0,652 0,307 0,149 2,96 1,66 0,718 0,35 0,196 
Before (g) 2,1709 2,1677 2,1524 2,1527 2,1574 2,155 2,1585 2,1671 2,1606 2,1584 
After (g) 2,2192 2,1897 2,1616 2,1572 2,1611 2,1946 2,1795 2,1778 2,1662 2,1605 
Dry weight 0,0483 0,022 0,0092 0,0045 0,0037 0,0396 0,021 0,0107 0,0056 0,0021 
g DW/L 1,2075 0,55 0,23 0,1125 0,0925 0,99 0,525 0,2675 0,14 0,0525 
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APPENDIX III- RAW DATA FROM ENZYME ASSAY OPTIMIZATION 
 
Each enzyme assay used in this project was optimized in respect of the amount of 
standards and enzyme added to reach endpoint within 2-3 minutes and measuring 
range from OD 0,1 to 0,8. The amount of standards and enzymes were change to find a 
suitable combination of the amounts added. OD measurements from each trail, reaction 
progression and the linear effect of changing amount of standards for each enzyme assay 
are shown below. The blue shaded columns indicate the optimized amounts of standards 
and enzymes added in each assay.  
 
G-6-P and F-6-P 
The optimized volumes were 5µL G-6-P and F-6-P standards, and 1µL G-6-P 
dehydrogenase and G-6-P isomerase. Raw data for each trial of optimization is 
presented in Table 3.   
    
Table 3-OD measurements from optimization of G-6-P and F-6-P enzyme assay 
 
 
  
G-6-P dehydrogenase 5µL 5µL 3µl 3µL 2µL 2µL 1µL 1µL
G-6-P isomerase 5µL 5µL 3µL 3µL 2µL 2µL 1µL 1µL
10mM G-6-P Stndard 5µL 10µL 5µL 10µL 5µL 10µL 5µL 10µL
10mM F-6-P Standard 5µL 10µL 5µL 10µL 5µL 10µL 5µL 10µL
0,5 minutes 0,277 0,53 0,26 0,509 0,267 0,512 0,259 0,461
1 minute 0,284 0,558 0,274 0,546 0,281 0,542 0,268 0,504
1,5 minutes 0,286 0,567 0,278 0,565 0,286 0,55 0,272 0,525
2 minutes 0,288 0,573 0,282 0,569 0,289 0,559 0,274 0,536
2,5 minutes 0,288 0,575 0,282 0,568 0,289 0,562 0,274 0,54
3 minutes 0,287 0,576 0,282 0,572 0,29 0,564 0,275 0,544
3,5 minutes 0,287 0,576 0,282 0,574 0,29 0,565 0,275 0,546
4 minutes 0,287 0,576 0,283 0,574 0,29 0,566 0,275 0,547
5 minutes 0,576 0,283 0,571
Delta OD 0,287 0,576 0,283 0,571 0,29 0,566 0,275 0,547
G-6-P isomerase added
0,5 minutes 0,2 0,35 0,18 0,274 0,198 0,315 0,21 0,215
1 minute 0,239 0,435 0,23 0,383 0,255 0,411 0,23 0,346
1,5 minutes 0,25 0,47 0,248 0,436 0,275 0,459 0,248 0,402
2 minutes 0,26 0,488 0,259 0,461 0,283 0,483 0,257 0,445
2,5 minutes 0,263 0,5 0,262 0,476 0,288 0,495 0,259 0,466
3 minutes 0,263 0,506 0,264 0,483 0,29 0,503 0,261 0,48
3,5 minutes 0,263 0,509 0,265 0,486 0,29 0,507 0,262 0,487
4 minutes 0,263 0,512 0,265 0,487 0,29 0,511 0,262 0,494
5 minutes 0,263 0,513 0,266 0,494 0,291 0,514 0,263 0,5
6 minutes 0,515 0,266 0,498 0,515 0,264 0,504
7 minutes 0,52
Delta OD 0,263 0,515 0,266 0,498 0,291 0,515 0,264 0,504
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A graphic presentation of the reaction progression for G-6-P and F-6-P using 5µL and 
10µL standard and 1µL and 2µL enzyme are shown below.  
 
 
Figure 27- Progression of enzyme reaction of A) G-6-P using G-6-P dehydrogenase and 10mM G-6-P standard 
and B) F-6-P using G-6-P isomerase and 10mM F-6-P 
 
Substrate as the limiting reactant is verified by the linear correlation of delta OD and 
increased amount of G-6-P and F-6-P standard added, Figure 28. 
  
 
Figure 28- Changes in delta OD as a result of varying the volumes of G-6-P and F-6-P standard added, using the 
enzymes G-6-P dehydrogenase and G-6-P isomerase in the respective reactions. 
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DHAP and F-1,6-BP 
The optimized volumes were 2µL DHAP and F-1,6-BP standards and 1µL G-3-P 
dehydrogenase and F-1,6-BP aldolase. Raw data for each trial of optimization is shown 
in Table 4.  
 
Table 4-OD measurements from optimization of DHAP and F-1,6-BP enzyme assay 
 
 
  
G-3-P dehydrogenase 2µL 2µL 2µL 2µL 2µL 1µL 1µL 1µL
F-1,6-BP aldolase 2µL 2µL 2µL 2µL 2µL 1µL 1µL 1µL
10mM DHAP Standard 5 µL 2µL 1µL 2µL 3µL 1µL 2µL 3µL
10mM F-1,6-BP Standard 6 µL 2µL 1µL 2µL 3µL 1µL 2µL 3µL
Before 0,65 0,638 0,712 0,757 0,704 0,682 0,752 0,713
0,5 minutes 0,411 0,54 0,669 0,662 0,574 0,647 0,675 0,59
1 minute 0,408 0,537 0,667 0,662 0,566 0,64 0,667 0,582
1,5 minutes 0,408 0,534 0,668 0,661 0,566 0,64 0,665 0,58
2 minutes 0,408 0,533 0,668 0,661 0,564 0,64 0,655 0,579
2,5 minutes 0,407 0,534 0,668 0,661 0,564 0,64 0,655 0,579
3 minutes 0,407 0,534 0,668 0,661 0,564 0,64 0,655 0,579
3,5 minutes
Delta OD 0,243 0,104 0,044 0,096 0,14 0,042 0,097 0,134
F-1,6-BP aldolase added
Before 0,407 0,534 0,668 0,661 0,564 0,637 0,655 0,579
0,5 minutes 0,06 0,213 0,54 0,402 0,266 0,541 0,507 0,35
1 minute 0,059 0,192 0,532 0,381 0,195 0,516 0,444 0,25
1,5 minutes 0,059 0,187 0,53 0,377 0,176 0,506 0,414 0,198
2 minutes 0,059 0,188 0,53 0,379 0,171 0,502 0,395 0,193
2,5 minutes 0,187 0,53 0,378 0,17 0,501 0,387 0,192
3 minutes 0,185 0,53 0,379 0,17 0,5 0,385 0,192
3,5 minutes 0,183 0,383
4 minutes 0,183 0,381
Delta OD 0,348 0,351 0,138 0,282 0,394 0,137 0,274 0,387
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A graphic presentation of the reaction progression for DHAP and F-1,6-BP using 1, 2 and 
3µL standard and 1µL and 2µL enzyme are given below.  
 
 
Figure 29-Progression of enzyme reaction of A) DHAP using G-3-P dehydrogenase and 10mM DHAP standard 
and B) F-1,6-BP using F-1,6-BP aldolase and 10mM F-1,6-BP standard 
 
Substrate as the limiting reactant is verified by the linear correlation of increased delta 
OD and increased amount of DHAP and F-1,6-BP standard added, Figure 30.   
 
 
Figure 30-Changes in delta OD as a result of varying the amount of DHAP and F-1,6-BP standard 
added, using G-3-P dehydrogenase and F-1,6-BP aldolase in the respective reactions. 
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Pyruvate 
Optimized volumes were 3µL pyruvate and 3µL lactate dehydrogenase. Raw data from 
each trial of optimization is shown in Table 5.  
 
Table 5- OD measurements from optimization of pyruvate enzyme assay 
 
 
A graphic presentation of the reaction progression for pyruvate using 3, 5, 7 and 10µL 
standard and 3µL lactate dehydrogenase are given below.  
 
 
Figure 31- Progression of enzyme reaction of 10mM pyruvate using 3µL lactate dehydrogenase 
Substrate as the limiting reactant is verified by the linear correlation of delta OD and 
increased amount of standard added, Figure 32.  
 
 
Figure 32-Change of delta OD as a result of varying the volume of pyruvate standard added using lactate 
dehydrogenase 
Lactate dehydrogenase 5 µL 5µL 5µL 2µL 3µL 4µL 3µL 3µL 3µL 3µL
0,1M Pyruvate Standard 1 µL 2 µL 5 µL 1µL 1µL 1µL
10 mM  Pyruvate Standard 3µL 5µL 7µL 10µL
Before 0,775 0,874 0,85 0,659 0,787 0,744 0,686 0,766 0,661 0,678
0,5 minutes 0,278 0,092 0,089 0,28 0,29 0,184 0,536 0,532 0,328 0,245
1 minute 0,236 0,087 0,09 0,204 0,252 0,135 0,532 0,508 0,306 0,191
1,5 minutes 0,232 0,086 0,091 0,178 0,232 0,126 0,52 0,504 0,298 0,169
2 minutes 0,228 0,086 0,089 0,159 0,219 0,116 0,52 0,503 0,297 0,157
2,5 minutes 0,23 0,086 0,089 0,15 0,223 0,111 0,52 0,502 0,297 0,151
3 minutes 0,23 0,087 0,089 0,147 0,228 0,111 0,52 0,502 0,296 0,15
3,5 minutes 0,23 0,146 0,226 0,113 0,52 0,502 0,296 0,148
4 minutes 0,23 0,144 0,225 0,111 0,52 0,502 0,296 0,147
Delta OD 0,545 0,787 0,761 0,515 0,562 0,633 0,166 0,264 0,365 0,531
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APPENDIX IV - MEASURING INTRA- AND EXTRACELLULAR 
METABOLITES IN METABOLITE EXTRACTS USING ENZYME ASSAYS 
 
Enzyme assays were used for analysis of glycolytic intermediates in intra-and 
extracellular extracts from the two sampling methods. Delta OD values from the extracts 
could be compared to delta OD from assays with standards and concentration in extracts 
calculated. Delta OD in three parallels for all extracts for both strains and both sampling 
method are show below. Delta OD of 0,000 indicates no metabolites in extracts. 
Moreover, addition of standards gave expected delta OD proving the functionality of 
each assay.  
 
Table 6- Delta OD values from analyses of G-6-P, F-6-P, DHAP, F-1,6-P and pyruvate and standards in extracts 
from CEN pk and BY 4743 cultures, applying direct quenching 
 
Parallel 1 2 3 average 1 2 3 average
sample 0 0 0 0,000 0 0 0 0,000
standard 0,276 0,251 0,251 0,259 0,298 0,264 0,264 0,275
sample 0 0,001 0 0,000 0 0,002 0 0,001
standard 0,317 0,277 0,286 0,293 0,31 0,291 0,276 0,292
sample 0 0 0 0,000 0 0,002 0 0,001
standard 0,254 0,256 0,275 0,262 0,245 0,253 0,26 0,253
sample 0 0,001 0 0,000 0 0 0 0,000
standard 0,276 0,28 0,279 0,278 0,249 0,25 0,243 0,247
Parallel 1 2 3 average 1 2 3 average
sample 0,002 0,001 0,001 0,001 0,002 0,001 0,001 0,001
standard 0,06 0,062 0,065 0,062 0,229 0,315 0,289 0,278
sample 0,001 0,001 0,003 0,003
standard 0,065 0,065 0,313 0,313
sample 0 0,001 0,001 0,001 0,001 0,001 0,001 0,001
standard 0,078 0,099 0,094 0,090 0,299 0,27 0,271 0,280
sample 0 0,002 0,001 0,001 0 0,001 0 0,000
standard 0,066 0,069 0,063 0,066 0,298 0,272 0,282 0,284
Parallel 1 2 3 average
sample 0,015 0,016 0,015 0,015
standard 0,36 0,359 0,359 0,359
sample 0,014 0,016 0,017 0,016
standard 0,364 0,365 0,369 0,366
sample 0,016 0,015 0,015 0,015
standard 0,37 0,362 0,361 0,364
sample 0,015 0,015 0,015 0,015
standard 0,364 0,366 0,366 0,365
G-6-P F-6-P
CEN pk intracellulært
CEN pk extracellulært
DHAP F-1,6-BP
Pyruvate
BY 4743, intracellulært
BY 4743, extracellulært
CEN pk extracellulært
BY 4743, intracellulært
BY 4743, extracellulært
CEN pk intracellulært
CEN pk extracellulært
BY 4743, intracellulært
BY 4743, extracellulært
CEN pk intracellulært
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Pyruvate was the first and only metabolite analyzed in extracts from the filtration 
protocol. Because the same results was seen as extracts from direct quenching, no other 
metabolites were analyzed. Results from filtration extracts are seen in Table 7.  
 
Table 7- Delta OD values from analyses of pyruvate and standard for CEN pk and BY 4743 using filtration 
prior to quenching 
 
 
No metabolites were detected when the culture was allocated in replica as in the above 
experiments. To increase the biomass analyzed in each extract, samples from a third 
culture was not allocated in replica. No metabolites were detected despite increased 
amount of biomass analyzed. Furthermore, addition of standards did no show expected 
delta OD in this experiment, and the functionality of assays could not be confirmed.  
 
Table 8- Delta OD values from analysis of metabolite extracts from BY4743 not allocated in replica after 
filtration and quenching. Addition of standards did not give the expected results, marked with red shading. 
 
Parallel 1 2 3 average
sample 0,004 0,003 0,004 0,004
standard 0,367 0,356 0,362 0,362
sample 0,002 0,006 0,012 0,007
standard 0,367 0,371 0,377 0,372
sample 0,004 0,002 0,004 0,003
standard 0,362 0,375 0,378 0,372
sample 0,008 0,004 0,006 0,006
standard 0,357 0,379 0,388 0,375
BY 4743, extracellulært
Pyruvate
CEN pk intracellulært
CEN pk extracellulært
BY 4743, intracellulært
Parallel 1 2 3 average 1 2 3 average
sample -0,001 0,002 0,001 0,001 -0 -0,002 0 -0,001
standard 0,287 0,284 0,306 0,292 0,27 0,275 0,282 0,276
sample -0,001 0,001 0 0,000 0,001 -0,003 -0,001 -0,001
standard 0,109 0,138 0,08 0,109 0,109 0,074 0,114 0,099
Parallel 1 2 3 average 1 2 3 average
sample -0,003 0,003 0,005 0,002 0,005 -0,001 0,001 0,002
standard 0,21 0,105 0,089 0,135 0,277 0,312 0,268 0,286
sample 0,004 0,004 -0,002 0,002 0,002 0,003 0,002 0,002
standard 0,008 0,015 0,088 0,037 0,011 0,023 0,068 0,034
Parallel 1 2 3 average
sample 0,007 0,006 0,003 0,005
standard 0,374 0,376 0,37 0,373
sample 0,021 0,021 0,017 0,020
standard 0,377 0,39 0,37 0,379
BY 4743, intracellulært
BY 4743, extracellulært
DHAP F-1,6-BP
BY 4743, intracellulært
BY 4743, extracellulært
G-6-P F-6-P
BY 4743, intracellulært
BY 4743, extracellulært
Pyruvate
APPENDIX V 
 
XV 
 
open name cas mol form mol wt RT open company IDfile name target ion q1 q1 ratio q1 %uncertaintyq2 q2 ratio q2 %uncertaintyq3 q3 ratio q3 %uncertaintyunc tp: 0=rel, 1=abs
Methylvalerat 1010 500 6,267 cmp10 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\11Nov10MCF_Methylvalerat+phenylpyruvat.D74 87 71,9 20 99 36,8 20 88 24,8 20 1
Tetrachloroethane 630206 C2H2Cl4 167,85 6,8569 cmpd005 C:\msdchem\1\DATA\METHODS\SKLMCFD2\24mar09MCF_d5-glu.D83 85 66,1 20 131 13,6 20 168 12 20 1
Malanoic acid 1008 500 6,949 cmp08 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\11Nov10MCF_malanoic acid+gamma aminobutyrat.D101 74 41,1 20 69 8,1 20 102 4,4 20 1
Pyruvate 127173 C3H4O3 88,06 7,1534 cmpd006 C:\msdchem\1\DATA\METHODS\SKLMCFD2\22jul08MCF_dilmix1_100-00.D89 117 40,6 20 85 14,3 20 57 16,2 20 1
3-methyl-2-oxovalerate 1033 500 7,527 cmp33 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_methyl-oxovalerate+diaminobutyrat.D85 144 6,8 20 86 5,5 20 84 5,36 20 1
Pentachloroethane 100000049 500 7,7721 cmpd011 C:\msdchem\1\DATA\METHODS\SKLMCFD2\10des08MCF_WT_1_FFi_1_2.D167 117 79,8 20 165 76,2 20 130 28,2 20 1
Fumarate-1 1110178 C4H404 116,07 8,32 cmpd015 C:\msdchem\1\DATA\METHODS\SKLMCFD2\22jul08MCF_dilmix2_100-00.D113 85 9,8 20 59 15,5 20 82 2,2 20 1
Fumarate-2 2110178 C4H404 116,07 8,3644 cmpd016 C:\msdchem\1\DATA\METHODS\SKLMCFD2\22jul08MCF_dilmix2_100-00.D113 85 49,4 20 59 2 ,8 20 82 5,3 20 1
d4-Succinate 14493426 C4H2D4O4 122,12 8,442 cmpd017 C:\msdchem\1\DATA\METHODS\SKLMCFD2\23jul08MCF_dilmix3_100-00.D119 117 15,2 20 91 14,9 20 58 33,2 20 1
Lactate 50215 C3H6O3 500 8,4847 cmpd018 C:\msdchem\1\DATA\METHODS\SKLMCFD2\24jul08MCF_dilmix5_100-00.D103 59 174,5 20 131 8,2 20 87 6,1 20 1
Methylglyoxal 1031 500 8,484 cmp31 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_methylglyoxal+aminovalerat.D103 131 9 20 130 8 20 87 6,2 20 1
Succinate 110156 C4H6O4 118,09 8,4976 cmpd019 C:\msdchem\1\DATA\METHODS\SKLMCFD2\23jul08MCF_dilmix4_100-00.D115 87 18,1 20 11 28,4 20 55 42,4 20 1
Hexachloroethane 67721 C2Cl6 236,7 9,3275 cmpd021 C:\msdchem\1\DATA\METHODS\SKLMCFD2\10des08MCF_WT_1_FFi_1_2.D201 117 86 20 166 45,7 20 203 63,9 20 1
b-hydroxypyruvat 1043 500 9,347 cmp43 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\11Nov10MCF_B-hydroxypyruvat+2-6-deaminopimelat.D201 117 76,4 20 119 73,8 20 199 65,1 20 1
Citraconate 1044 500 9,526 cmp44 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\11Nov10MCF_Citraconate+Putresine.D127 99 22,6 20 99 22,6 20 126 9,4 20 1
Benzoat 1002 500 9,637 cmp02 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\11Nov10MCF_Benzoat+Allantoin.D105 77 59 20 136 47,5 20 106 8,9 20 1
Citramalat 1021 500 9,95 cmp21 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_Citramalat+Serine.D117 85 61,2 20 75 ,5 20 101 5,3 20 1
Malate-2 26915157 C4H6O5 134,09 9,9752 cmpd025 C:\msdchem\1\DATA\METHODS\SKLMCFD2\23jul08MCF_dilmix3_100-00.D103 71 74 20 61 32,7 20 59 19 20 1
d3-alanine 63546270 C3H4D3NO2 500 10,042 cmpd026 C:\msdchem\1\DATA\METHODS\SKLMCFD2\24jul08MCF_dilmix6_100-00.D105 61 19 20 73 9,7 20 59 16,3 20 1
Glycine 56406 C2H5NO2 500 10,064 cmpd027 C:\msdchem\1\DATA\METHODS\SKLMCFD2\23jul08MCF_dilmix4_100-00.D88 147 5,6 20 56 9,6 20 116 2,7 20 1
Alanine 56417 C3H7NO2 89,09 10,075 cmpd028 C:\msdchem\1\DATA\METHODS\SKLMCFD2\24jul08MCF_dilmix5_100-00.D102 58 17,8 20 70 9,5 20 56 5,2 20 1
Methoxyamine 1029 500 10,183 cmp29 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_methoxyamine+methionine.D74 119 96,1 20 132 25,9 20 104 22 20 1
Nicotinat 1036 500 10,382 cmp36 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_Nicotinat+acetyl-L-glutamat.D106 78 74,1 20 137 71,6 20 136 34,9 20 1
Phenylacetat 1014 500 10,948 cmp14 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\11Nov10MCF_Phenylacetat+N-glycyl-proline.D91 150 53,9 20 65 5,9 20 92 100 20 1
M-toluate 1035 500 11,437 cmp35 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_M-toluate+2-oxobutyrat.D119 91 58,4 20 150 54,2 20 120 10,8 20 1
2-aminobutyrat 1016 500 11,582 cmp16 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_2-aminobutyrat+hydrproline.D116 84 8,2 20 117 7,5 20 146 6,5 20 1
Adipat 1045 500 11,96 cmp45 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\11Nov10MCF_Adipat+Histamine.D114 111 76,1 20 143 75 20 101 70,8 20 1
d8-valine 35045728 C5H3D8NO2 125,2 11,997 cmpd039 C:\msdchem\1\DATA\METHODS\SKLMCFD2\24jul08MCF_dilmix6_100-00.D138 106 18,7 20 11 9,9 20 147 6,7 20 1
Valine 72184 C5H11NO2 117,15 12,086 cmpd040 C:\msdchem\1\DATA\METHODS\SKLMCFD2\22jul08MCF_dilmix1_100-00.D130 98 24,9 20 55 13,3 20 115 21,6 20 1
a-ketoglutarate 328507 C5H6O5 146,11 12,097 cmpd041 C:\msdchem\1\DATA\METHODS\SKLMCFD2\22jul08MCF_dilmix2_100-00.D115 87 11,2 20 130 3,3 20 55 43,2 20 1
2-isopropylmalate 1025 500 12,425 cmp25 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_i-propylmalate+hydr-aspartat.D145 101 36,5 20 113 32,8 20 127 20 20 1
a-ketoadipat 1027 500 13,236 cmp27 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_ketoadiapt+4-imidazoleacry.D129 101 63,7 20 157 3,2 20 97 12,4 20 1
Leucine 61905 C6H13NO2 131,17 13,275 cmpd048 C:\msdchem\1\DATA\METHODS\SKLMCFD2\23jul08MCF_dilmix4_100-00.D144 88 72,2 20 102 21,1 20 128 5,7 20 1
APPENDIX V- CHEMSTATION PART OF THE NEW MCF-DRS LIBRARY 
In the process of building a Deconvolution Reporting Software library, mass to charge ratio for TI, Q1, Q2 and Q3 were manually plotted 
for each metabolite. So were names for each metabolite, each qualifier ratio to target ion, a certain CAS number, retention times, 
company ID, file name and uncertainties in percentage. The library composed in this project includes 38 known compounds from an 
already existing library and 43 new compounds. The manual typed information for each metabolites included in the new library are 
shown in  
 
Table 9 below.  
 
Table 9- Complete information for each metabolite included in the new DRS library sorted by retention times 
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Isoleucine-1 1443798 C6H13NO2 131,17 13,341 cmpd050 C:\msdchem\1\DATA\METHODS\SKLMCFD2\23jul08MCF_dilmix3_100-00.D144 88 51,8 20 69 17,6 20 76 8,9 20 1
Serine-1 156451 C3H7NO3 105,09 13,419 cmpd053 C:\msdchem\1\DATA\METHODS\SKLMCFD2\23jul08MCF_dilmix4_100-00.D115 146 81,6 20 102 14,9 20 59 68,5 20 1
Isoleucine-2 2443798 C6H13NO2 131,17 13,442 cmpd054 C:\msdchem\1\DATA\METHODS\SKLMCFD2\23jul08MCF_dilmix3_100-00.D144 88 51,1 20 69 17,2 20 76 8,8 20 1
g-aminobutyrat 1009 500 13,562 cmp09 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\11Nov10MCF_malanoic acid+gamma aminobutyrat.D102 88 66,5 20 112 43,1 20 144 23,1 20 1
Serine 1022 500 13,692 cmp22 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_Citramalat+Serine.D89 131 71,2 20 127 52,1 20 99 31,9 20 1
Malate-1 16915157 C4H6O5 134,09 13,775 cmpd058 C:\msdchem\1\DATA\METHODS\SKLMCFD2\23jul08MCF_dilmix3_100-00.D75 117 74,2 20 11 56,4 20 101 10,1 20 1
Threonine 1041 500 13,893 cmp41 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_threonine+ornithine.D115 147 23,7 20 100 2 ,9 20 87 15,1 20 1
L-homoserine 1006 500 13,904 cmp06 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\11Nov10MCF_L-homoserine+kynurenine.D115 100 87 20 10 58,7 20 128 13,9 20 1
Proline 147853 C5H9NO2 115,13 13,941 cmpd059 C:\msdchem\1\DATA\METHODS\SKLMCFD2\24jul08MCF_dilmix5_100-00.D128 82 11,9 20 59 8,5 20 187 3,7 20 1
Asparagine 70473 C4H8N2O3 132,12 14,019 cmpd061 C:\msdchem\1\DATA\METHODS\SKLMCFD2\22jul08MCF_dilmix2_100-00.D127 56 31,3 20 146 1 ,1 20 83 8,9 20 1
O-acetyl-L-serine 1012 500 14,492 cmp12 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\11Nov10MCF_O-acetyl-L-Serine+Hippurat.D105 161 80,2 20 77 75,1 20 117 63,5 20 1
Aspartate 56848 C4H7NO4 133,1 14,963 cmpd071 C:\msdchem\1\DATA\METHODS\SKLMCFD2\24jul08MCF_dilmix5_100-00.D160 128 42,9 20 118 24,9 20 86 22,2 20 1
Citrate 77929 C6H8O7 192,12 15,019 cmpd072 C:\msdchem\1\DATA\METHODS\SKLMCFD2\22jul08MCF_dilmix1_100-00.D143 101 57,9 20 175 13,2 20 69 6,9 20 1
5-aminovalerat 1032 500 15,214 cmp32 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_methylglyoxal+aminovalerat.D88 157 41,9 20 10 40 20 130 33 20 1
Salicylat 1039 500 15,802 cmp39 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_Salycylat+beta MAA.D135 121 40,7 20 92 4 ,4 20 165 34,2 20 1
Anthraniate 1018 500 15,815 cmp18 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_Anthraniate.D146 177 53 20 90 3 ,2 20 118 4,6 20 1
Serine-2 256451 C3H7NO3 105,09 15,863 cmpd081 C:\msdchem\1\DATA\METHODS\SKLMCFD2\23jul08MCF_dilmix4_100-00.D100 176 14,2 20 159 7,7 20 127 7,3 20 1
Glutamine 56859 C5H10N2O3 500 15,897 cmpd082 C:\msdchem\1\DATA\METHODS\SKLMCFD2\24jul08MCF_dilmix5_100-00.D141 109 36,5 20 56 2 ,4 20 82 11,8 20 1
d5-glutamate 100000013 C5H4D5NO4 152,16 16,517 cmpd089 C:\msdchem\1\DATA\METHODS\SKLMCFD2\22jul08MCF_dilmix1_100-00.D179 118 73,4 20 147 59,2 20 207 7,9 20 1
Glutamate 56860 C5H9NO4 147,13 16,585 cmpd090 C:\msdchem\1\DATA\METHODS\SKLMCFD2\23jul08MCF_dilmix3_100-00.D114 174 96,5 20 142 86,1 20 82 25,5 20 1
N-acetyl-L-glutamat 1037 500 16,661 cmp37 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_Nicotinat+acetyl-L-glutamat.D116 84 93,6 20 158 92,9 20 144 48 20 1
OH-Proline 51354 C5H9NO3 131,13 16,719 cmpd091 C:\msdchem\1\DATA\METHODS\SKLMCFD2\22jul08MCF_dilmix2_100-00.D144 126 12,3 20 8 12,4 20 68 8 20 1
Hydroxyproline 1017 500 16,891 cmp17 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_2-aminobutyrat+hydrproline.D144 126 13,6 20 82 2,3 20 145 7,7 20 1
Methionine 1030 500 16,948 cmp30 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_methoxyamine+methionine.D115 147 97,1 20 114 41 20 128 33,2 20 1
b-methylamino-L-alanine 1040 500 17,713 cmp40 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_Salycylat+beta MAA.D102 157 10,3 20 173 9,3 20 189 8,1 20 1
Cysteine 52904 C3H7NO2S 121,16 17,926 cmpd099 C:\msdchem\1\DATA\METHODS\SKLMCFD2\23jul08MCF_dilmix3_100-00.D192 176 82,8 20 132 48,4 20 146 43,8 20 1
Isocitrate 320774 C6H8O7 192,12 18,163 cmpd103 C:\msdchem\1\DATA\METHODS\SKLMCFD2\24jul08MCF_dilmix6_100-00.D129 157 46,6 20 201 34,4 20 101 2,1 20 1
Phenylalanine 63912 C9H11NO2 165,19 18,262 cmpd104 C:\msdchem\1\DATA\METHODS\SKLMCFD2\23jul08MCF_dilmix4_100-00.D162 91 64 20 146 51,6 20 178 27,6 20 1
Putresine 1005 500 18,369 cmp05 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\11Nov10MCF_Citraconate+Putresine.D88 128 34 20 172 2 ,9 20 117 14,1 20 1
Phenylpyruvat 1011 500 18,395 cmp11 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\11Nov10MCF_Methylvalerat+phenylpyruvat.D118 119 99 20 90 89 20 192 81,7 20 1
Hippurat 1013 500 14,511 cmp13 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\11Nov10MCF_O-acetyl-L-Serine+Hippurat.D105 134 35,1 20 193 8,1 20 161 16,3 20 1
Threo-b-hydroxyaspartat 1026 500 18,591 cmp26 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_i-propylmalate+hydr-aspartat.D202 146 61,9 20 234 37,9 20 126 29,2 20 1
4-imidazoleacrylate 1028 500 19,191 cmp28 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_ketoadiapt+4-imidazoleacry.D179 210 97 20 107 45,3 20 152 41,9 20 1
Allantoin 1003 500 19,195 cmp03 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\11Nov10MCF_Benzoat+Allantoin.D161 129 38,6 20 146 8,5 20 204 7,9 20 1
2,4-diaminobutyrate 1034 500 19,28 cmp34 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_methyl-oxovalerate+diaminobutyrat.D114 147 56,2 20 115 45,1 20 88 44,8 20 1
4-aminobenzoat 1001 500 19,558 cmp01 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\11Nov10MCF_B-alanin+4-aminobenzoat.D178 209 92,9 20 146 57,8 20 134 17,4 20 1
Cadaverine 1019 500 19,58 cmp19 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_Cadaverine+ferulate.D88 143 19,1 20 10 2,7 20 187 8,1 20 1
Oxaloacetat 1038 500 19,936 cmp38 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_oxaloacetat.D185 143 71,3 20 153 68,8 20 125 36,6 20 1
Histamine 1046 500 20,047 cmp46 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\11Nov10MCF_Adipat+Histamine.D152 140 66,2 20 8 53 20 107 12,6 20 1
p-coumarate 1023 500 20,302 cmp23 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_coumarat+Serotonin.D161 236 62,2 20 133 29,6 20 205 16,4 20 1
Ornithine 70268 C5H12N2O2 132,16 20,485 cmpd122 C:\msdchem\1\DATA\METHODS\SKLMCFD2\22jul08MCF_dilmix2_100-00.D128 88 14 20 230 11,2 20 198 8,1 20 1
N-glycyl-proline 1015 500 21,525 cmp15 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\11Nov10MCF_Phenylacetat+N-glycyl-proline.D128 88 32,8 20 212 23 20 153 15,1 20 1
Lysine 56871 C6H14N2O2 146,19 21,585 cmpd137 C:\msdchem\1\DATA\METHODS\SKLMCFD2\23jul08MCF_dilmix3_100-00.D142 88 22,7 20 15 14,2 20 244 8,3 20 1
Histidine 71001 C6H9N3O2 500 22,174 cmpd143 C:\msdchem\1\DATA\METHODS\SKLMCFD2\23jul08MCF_dilmix4_100-00.D210 226 57,3 20 19 63,7 20 139 90,1 20 1
Ferulate 1020 500 22,254 cmp20 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_Cadaverine+ferulate.D266 222 71,4 20 19 63,5 20 207 50,7 20 1
Tyrosine 60184 C9H11NO3 181,19 23,25 cmpd151 C:\msdchem\1\DATA\METHODS\SKLMCFD2\24jul08MCF_dilmix5_100-00.D121 236 83,1 20 16 56,1 20 161 20,7 20 1
2,6-deaminopimelat 1004 500 23,757 cmp04 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\11Nov10MCF_B-hydroxypyruvat+2-6-deaminopimelat.D200 140 69,7 20 168 3,1 20 201 12,3 20 1
Tryptophan 73223 C11H12N2O2 204,23 25,062 cmpd164 C:\msdchem\1\DATA\METHODS\SKLMCFD2\22jul08MCF_dilmix1_100-00.D130 276 9,4 20 77 4,6 20 103 4,4 20 1
Serotonine 1024 500 26,901 cmp24 C:\msdchem\1\DATA\Brukere\AMH 2010-11\NEW STANDARDS\15Nov10MCF_coumarat+Serotonin.D218 231 82,9 20 306 45,2 20 159 39,2 20 1
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APPENDIX VI- CALCULATIONS OF YIELD AND GROWTH RATE 
 
Glucose concentrations in preliminary studies were 5g/L. Applying the same glucose 
concentration in fermenter cultivation, OD in exponential phase were too low for 
sampling. Glucose concentration was therefore adjusted to 80g/L, resulting in late 
exponential phase appearing around OD 8. This was believed to give enough biomass for 
metabolite analysis. Yield biomass per gram glucose (Y) and growth rate (µmax) were 
calculated for 5g/L and 80g/L glucose in fermenter cultivation, showed in Table 10. 
Complete calculations for 5g/L are shown below.   
 
Calculation of yield and growth rate for cultivation with 5g/L glucose 
 
YIELD:  
Max OD = 1,968    
g DW/L corr. factor = 2,5   
g DW/L = 
     
   
= 0,787   
Y5g/l glu = 
           
            
 
Y5g/L glu = 0,157 g DW/ g glucose 
 
 
GROWTH RATE: 
µmax = 
         
     
 
µmax = 
               
         
 
µmax = 0,412 h-1
 
 
Table 10- Calculated yield and growth rate for the two glucose concentrations 
Glucose concentration 
(g/L) 
Yield (g DW/g glucose) Growth rate-µmax (h-1) 
5 0,157 0,412 
80 0,085 0,490 
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APPENDIX VII- METABOLIC CHANGES FOR SINGLE METABOLITES 
 
In this report metabolic changes from experiments with 0,1mM and 0,5mM 5-fluorouracil are presented separately. However, it is also 
interesting to study how different concentrations affect each and every metabolite. Figure 33 and Figure 34 presents metabolic changes 
caused by different concentrations of 5-fluorouracil for single metabolites during sampling interval. Point of nutrient limitation is not 
shown.  
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Figure 33- Metabolic changes before, at the time and after stress exposure by 0,1mM and 0,5mM 5-fluorouracil for A) Succinate, B) Alanine, 
C) Aspartate and D) Valine  
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Figure 34- Metabolic change before, at the time and after stress exposure of 0,1mM and 0,5mM 5-fluorouracil for A) Glutamate, B) Lysine, 
C) Histidine and D) Tyrosine 
  
 
